Dark | Light
# ![@MarcJacksonLA Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::4058194633.png) @MarcJacksonLA stock setter

Several companies across various sectors have recent target changes from analysts. Notable changes include upgrades and downgrades for companies such as American Tower, EOG Resources, and Aptiv. Additionally, some companies like Alaska Airlines and UnitedHealth have made significant announcements that may impact their stock performance. Analysts are also showing interest in companies like Neurocrine Biosciences and Faraday Future.

### Engagements: [------] [#](/creator/twitter::4058194633/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4058194633/c:line/m:interactions.svg)

- [--] Week [-------] +13%
- [--] Month [-------] +84%
- [--] Months [---------] -16%
- [--] Year [---------] +21%

### Mentions: [---] [#](/creator/twitter::4058194633/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4058194633/c:line/m:posts_active.svg)

- [--] Week [-----] +4.20%
- [--] Month [-----] +9.40%
- [--] Months [------] +1.90%
- [--] Year [------] +28%

### Followers: [-----] [#](/creator/twitter::4058194633/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4058194633/c:line/m:followers.svg)

- [--] Week [-----] +0.20%
- [--] Month [-----] +0.89%
- [--] Months [-----] +6.50%
- [--] Year [-----] +27%

### CreatorRank: [-------] [#](/creator/twitter::4058194633/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4058194633/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  91.34% [cryptocurrencies](/list/cryptocurrencies)  #5225 [technology brands](/list/technology-brands)  13.38% [financial services](/list/financial-services)  #869 [finance](/list/finance)  7.27% [countries](/list/countries)  6.16% [currencies](/list/currencies)  2.84% [automotive brands](/list/automotive-brands)  2.45% [exchanges](/list/exchanges)  1.01% [fashion brands](/list/fashion-brands)  0.67%

**Social topic influence**
[target](/topic/target) #600, [$barcl](/topic/$barcl) #45, [morgan stanley](/topic/morgan-stanley) #27, [bank of](/topic/bank-of) #358, [bank of america](/topic/bank-of-america) #67, [morgan](/topic/morgan) #93, [health](/topic/health) 2.6%, [$19](/topic/$19) #34, [$21](/topic/$21) #27, [bank](/topic/bank) #289

**Top accounts mentioned or mentioned by**
[@medtechdive](/creator/undefined) [@statnews](/creator/undefined) [@biopharmadive](/creator/undefined) [@barchart](/creator/undefined) [@streetinsider](/creator/undefined) [@fwpharma](/creator/undefined) [@businessinsider](/creator/undefined) [@bs](/creator/undefined) [@techzine](/creator/undefined) [@ft](/creator/undefined) [@bitcoinmagazine](/creator/undefined) [@yachmod](/creator/undefined) [@mattkiu](/creator/undefined) [@imcryptopus](/creator/undefined) [@darrenc777](/creator/undefined) [@itsa68891](/creator/undefined) [@james_wilsfile](/creator/undefined) [@mitchellreed09](/creator/undefined) [@kristinadavis90](/creator/undefined) [@cameron_br_pres](/creator/undefined)

**Top assets mentioned**
[Morgan Stanley (MS)](/topic/morgan-stanley) [Bank of America (BAC)](/topic/bank-of-america) [Born in [--] (19)](/topic/$19) [2131KOBUSHIDE (21)](/topic/$21) [HSBC Holdings PLC (HSBC)](/topic/$hsbc) [The 99% Community (99)](/topic/$99) [The Official [--] Coin (93)](/topic/$93) [Johnson & Johnson (JNJ)](/topic/$jnj) [The Official [--] coin (76)](/topic/$76) [Novartis AG (NVS)](/topic/$nvs) [69Coin (69)](/topic/$69) [Flutter Entertainment plc (FLUT)](/topic/$flut) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [AstraZeneca PLC (AZN)](/topic/$azn) [Atlassian Corporation PLC (TEAM)](/topic/$team) [Eli Lilly and Company (LLY)](/topic/$lly) [Now Coin (NOW)](/topic/$now) [Basilisk (BSX)](/topic/$bsx) [PayPal Holdings Inc (PYPL)](/topic/$pypl) [Legend Biotech Corp (LEGN)](/topic/$legn) [GSK plc (GSK)](/topic/$gsk) [DuPont de Nemours Inc (DD)](/topic/$dd) [The Official [--] Coin (89) (89)](/topic/$89) [monday.com Ltd. (MNDY)](/topic/$mndy) [CatCoin (CAT)](/topic/$cat) [Teradyne, Inc. (TER)](/topic/$ter) [Synthetify (SNY)](/topic/$sny) [Novo-Nordisk (NVO)](/topic/$nvo) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Walmart, Inc. (WMT)](/topic/$wmt) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Tapestry, Inc. (TPR)](/topic/$tpr) [Amgen, Inc. (AMGN)](/topic/$amgn) [Popular Inc (BPOP)](/topic/$bpop) [Biogen Inc (BIIB)](/topic/$biib) [Inspect (INSP)](/topic/$insp) [Rapids (RPD)](/topic/$rpd) [Doximity, Inc. (DOCS)](/topic/$docs) [Applied Materials, Inc. (AMAT)](/topic/$amat) [Devon Energy Corp (DVN)](/topic/$dvn) [Baker Hughes Co (BKR)](/topic/$bkr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Pinterest, Inc. (PINS)](/topic/$pins) [Evolent Health, Inc Class A Common Stock (EVH)](/topic/$evh) [AbbVie Inc (ABBV)](/topic/$abbv) [Copiosa Coin (COP2)](/topic/$cop) [Waystar Holding Corp (WAY)](/topic/$way) [Lumentum Holdings Inc. Common Stock (LITE)](/topic/$lite) [AME Chain (AME)](/topic/$ame) [Emerson Electric Co. (EMR)](/topic/$emr) [Western Digital Corp (WDC)](/topic/$wdc) [Trade Desk, Inc. (TTD)](/topic/$ttd) [Erasca, Inc.  (ERAS)](/topic/$eras) [Intuit Inc. (INTU)](/topic/$intu) [Datadog Inc (DDOG)](/topic/$ddog) [Analog Devices, Inc. (ADI)](/topic/$adi) [Orochi Network (ON)](/topic/$on) [Regal Rexnord, Corp. (RRX)](/topic/$rrx) [Coca-Cola Co (KO)](/topic/$ko) [Klarna Group plc (KLAR)](/topic/$klar) [Boston Scientific Corporation (BSX)](/topic/boston-scientific) [Zimmer Biomet Holdings Inc (ZBH)](/topic/$zbh) [Evommune, Inc. (EVMN)](/topic/$evmn) [Praxis Precision Medicines, Inc. (PRAX)](/topic/$prax) [Marriott International Inc (MAR)](/topic/$mar) [MKS Instruments Inc (MKSI)](/topic/$mksi) [Royalty Pharma plc (RPRX)](/topic/$rprx) [Duolingo, Inc.  (DUOL)](/topic/$duol) [Zillow Group, Inc. (ZG)](/topic/$zg) [Adobe, Inc. (ADBE)](/topic/$adbe) [Lam Research Corporation (LRCX)](/topic/$lrcx) [Paylocity Holding, Corp. (PCTY)](/topic/$pcty) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Roper Technologies Inc (ROP)](/topic/$rop) [ArcelorMittal (MT)](/topic/$mt) [Moon Tropica (CAH)](/topic/$cah) [Snap, Inc. (SNAP)](/topic/$snap)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$BDTX -Piper Sandler lowers Black Diamond Therapeutics target to $8 from $9 Overweight - $BGS -Cowen lifts B&G Foods target to $3.50 from $3 Sell -"  
[X Link](https://x.com/MarcJacksonLA/status/2012262203336819190)  2026-01-16T20:34Z [----] followers, [---] engagements


"$CROX -KeyBanc downgrades Crocs to Sector Weight from Overweight - $CTRE -Citizens JMP initiates CareTrust REIT coverage at Market Outperform $44 target - $CTSH -Berenberg Bank initiates Cognizant coverage at Buy $107 target -Citi raises target to $86 from $75 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2014415306438164781)  2026-01-22T19:10Z [----] followers, [---] engagements


"$ADP -Cantor Fitzgerald initiates Automatic Data Processing coverage at Overweight $306 target - $AESI -Stephens lowers Atlas Energy target to $16 from $20 Overweight - $AEYE -HC Wainwright lowers Audioeye target to $18 from $22 Buy - $AFRM -Needham upgrades Affirm to Buy from Hold $100 target - https://twitter.com/i/web/status/2016301042418516344 https://twitter.com/i/web/status/2016301042418516344"  
[X Link](https://x.com/MarcJacksonLA/status/2016301042418516344)  2026-01-28T00:03Z [----] followers, [---] engagements


"$ATKR -Roth raises Atkore target to $77 from $71 Buy -Citi raises target to $74 from $64 Neutral -RBC raises target to $71 from $64 Sector Perform - $AVNW -Roth lowers Aviat Networks target to $38 from $41 Buy -B. Riley raises target to $36 from $35 Buy - $AXP -UBS lowers American Express target to $395 from $414 Neutral - https://twitter.com/i/web/status/2019112912640704969 https://twitter.com/i/web/status/2019112912640704969"  
[X Link](https://x.com/MarcJacksonLA/status/2019112912640704969)  2026-02-04T18:16Z [----] followers, [---] engagements


"$CDP -Evercore raises COPT Defense target to $36 from $34 Outperform - $CI -RBC lowers Cigna target to $333 from $344 Outperform -Barclays lowers target to $303 from $305 Overweight -Leerink raises target to $297 from $270 Market Perform -"  
[X Link](https://x.com/MarcJacksonLA/status/2019930275179069525)  2026-02-07T00:24Z [----] followers, [---] engagements


"$BSY -Oppenheimer lowers Bentley Systems target to $53 from $65 Outperform - $BTU -Jefferies raises Peabody Energy target to $44 from $42 Buy - $CAKE -Morgan Stanley raises Cheesecake Factory target to $50 from $49 Underweight - $CAMT -Needham raises Camtek target to $160 from $135 Buy - https://twitter.com/i/web/status/2013718414473470346 https://twitter.com/i/web/status/2013718414473470346"  
[X Link](https://x.com/MarcJacksonLA/status/2013718414473470346)  2026-01-20T21:00Z [----] followers, [---] engagements


"$AAP -Northcoast Research upgrades Advance Auto Parts to Buy from Neutral $55 target - $ACDC -Morgan Stanley raises ProFrac target to $4 from $3.50 Underweight - $ACET -HC Wainwright raises Adicet Bio target to $50 from $9 on clinical progress Reiterates Buy rating https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-adicet-bio-stock-price-target-to-50-on-clinical-progress-93CH-4457504 https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-adicet-bio-stock-price-target-to-50-on-clinical-progress-93CH-4457504"  
[X Link](https://x.com/MarcJacksonLA/status/2014025443117244841)  2026-01-21T17:20Z [----] followers, [---] engagements


"$BIIB -Bernstein lowers Biogen target to $191 from $197 Market Perform - $BLK -CICC raises BlackRock target to $1250 from $1000 - $BPOP -Bank of America upgrades Popular to Buy from Neutral $156 target - $BSX -Barclays lowers Boston Scientific target to $124 from $136 Overweight"  
[X Link](https://x.com/MarcJacksonLA/status/2018756421731627206)  2026-02-03T18:40Z [----] followers, [---] engagements


"$BSX -UBS lowers Boston Scientific target to $120 from $140 Buy -Morgan Stanley lowers target to $118 from $130 Overweight -Mizuho lowers target to $115 from $140 Outperform -RBC lowers target to $115 from $130 Outperform -Canaccord lowers target to $112 from $131 Buy -Citi lowers target to $102 from $130 Buy -Baird lowers target to $101 from $118 Outperform -Goldman lowers target to $99 from $102 Buy -Needham lowers target to $97 from $121 Buy -Evercore lowers target to $96 from $112 Outperform -Truist lowers target to $95 from $120 Buy -Wells Fargo lowers target to $94 from $125 Overweight"  
[X Link](https://x.com/MarcJacksonLA/status/2019482075062235564)  2026-02-05T18:43Z [----] followers, [---] engagements


"$BSX Boston Scientific Stock Price Steadies After Historic Plunge as Investors Zero In on Heart Rhythm Outlook https://ts2.tech/en/boston-scientific-stock-price-steadies-after-historic-plunge-as-investors-zero-in-on-heart-rhythm-outlook/ https://ts2.tech/en/boston-scientific-stock-price-steadies-after-historic-plunge-as-investors-zero-in-on-heart-rhythm-outlook/"  
[X Link](https://x.com/MarcJacksonLA/status/2019822614123061433)  2026-02-06T17:16Z [----] followers, [---] engagements


"$CPAY -Mizuho raises Corday target to $340 from $320 Neutral - $CPT -Stifel lowers Camden Property Trust target to $118.50 from $120.50 Buy - $CRSR -Wedbush lowers Corsair Gaming target to $7 fro $9 Outperform -B. Riley lowers target to $6 from $7.50 Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/2019940491442508214)  2026-02-07T01:05Z [----] followers, [---] engagements


"$BSX $MDT $ABT $JNJ Boston Scientific Farapulse PFA Outperforms Thermal Ablation in Study https://www.massdevice.com/boston-scientific-farapulse-outperforms-thermal-study/ https://www.massdevice.com/boston-scientific-farapulse-outperforms-thermal-study/"  
[X Link](https://x.com/MarcJacksonLA/status/2021030562811740352)  2026-02-10T01:16Z [----] followers, [---] engagements


"$AMD -Evercore raises Advanced Micro Devices target to $328 from $283 Outperform -Benchmark maintains $325 target Buy -UBS lowers target to $310 from $330 Buy -KeyBanc raises target to $300 from $270 Overweight -Rosenblatt Roth maintain $300 target Buy -Wedbush maintains $290 target Outperform -Truist raises target to $283 from $277 Buy -Morgan Stanley lowers target to $255 from $260 = Weight -Bernstein raises target to $235 from $225 Market Perform https://twitter.com/i/web/status/2019109911221924242 https://twitter.com/i/web/status/2019109911221924242"  
[X Link](https://x.com/MarcJacksonLA/status/2019109911221924242)  2026-02-04T18:04Z [----] followers, [---] engagements


"$PYPL PayPal's former president slams the company says it's lost its 'mojo' and 'ability to compete' via @businessinsider https://www.businessinsider.com/paypal-former-president-david-marcus-lost-mojo-criticism-2026-2utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter https://www.businessinsider.com/paypal-former-president-david-marcus-lost-mojo-criticism-2026-2utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter"  
[X Link](https://x.com/MarcJacksonLA/status/2019214790393229488)  2026-02-05T01:01Z [----] followers, [---] engagements


"$APP -UBS lowers AppLovin target to $686 from $840 Buy - $ARWR -HC Wainwright reiterates Arrowhead Pharmaceuticals $100 target Buy - $AXP -Evercore lowers American Express target to $393 from $400 In-Line - $BCO -Truist raises Brink's target to $163 from $138 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2021370037853200580)  2026-02-10T23:45Z [----] followers, [---] engagements


"$SPRY - ARS Pharmaceuticals Announces FDA Approval of neffy [--] mg (epinephrine nasal spray) for Type I Allergic Reactions Including Anaphylaxis in Pediatric Patients Weighing [--] to [--] Kilograms - https://www.globenewswire.com/news-release/2025/03/05/3037769/0/en/ARS-Pharmaceuticals-Announces-FDA-Approval-of-neffy-1-mg-epinephrine-nasal-spray-for-Type-I-Allergic-Reactions-Including-Anaphylaxis-in-Pediatric-Patients-Weighing-15-to-30-Kilogra.html"  
[X Link](https://x.com/MarcJacksonLA/status/1897414479799009591)  2025-03-05T22:30Z [----] followers, [---] engagements


"$ABCL $LLY $ABBV $NVS -AbCellera Biologics: Fueling Growth Through Strategic Partnerships R&D - https://www.ainvest.com/news/abcellera-biologics-fueling-growth-strategic-partnerships-reinvention-2506/ https://www.ainvest.com/news/abcellera-biologics-fueling-growth-strategic-partnerships-reinvention-2506/"  
[X Link](https://x.com/MarcJacksonLA/status/1940194552029356318)  2025-07-01T23:43Z [----] followers, [----] engagements


"$IDXX -Morgan Stanley raises IDEXX Laboratories target to $765 from $722 Overweight - $INKT -HC Wainwright upgrades MiNK Therapeutics to Buy from Neutral $35 target - $INSP -Leekrink lowers Inspire Medical Systems target to $97 from $116 Market Perform -"  
[X Link](https://x.com/MarcJacksonLA/status/1956491802581872921)  2025-08-15T23:02Z [----] followers, [---] engagements


"$USB -Truist raises US Bancorp target to $51 from $49 Hold - $VCEL BTIG downgrades Vericel to Neutral from Buy - $VTEX -Jefferies upgrades VTEX to Buy from Hold Lowers target to $6.50 from $7.30 - $WCN -Citi lowers Waste Connections target to $199 from $204 Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/1968412157646688385)  2025-09-17T20:30Z [----] followers, [---] engagements


"$IFF -Berenberg Bank lowers International Flavors & Fragrances target to $78.30 from $78.80 Hold - $IMUX -Chardan Capital initiates Immunic coverage Buy $13 target - $INTC -Deutsche Bank raises Intel target to $30 from $23 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/1972737049733271902)  2025-09-29T18:55Z [----] followers, [---] engagements


"$ODFL -UBS raises Old Dominion Freight target to $164 from $155 Neutral - $OEC -Mizuho lowers Orion target to $7 from $9 Underperform - $OLN -Mizuho raises Olin target to $26 from $23 Neutral - $OSIS -Oppenheimer raises OSI Systems target to $280 from $270 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1974625415068262771)  2025-10-04T23:59Z [----] followers, [---] engagements


"$IMMP Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress [----] https://www.stocktitan.net/news/IMMP/primary-endpoint-met-in-eftisarc-neo-phase-ii-evaluating-neoadjuvant-oz0c0akcfofz.html https://www.stocktitan.net/news/IMMP/primary-endpoint-met-in-eftisarc-neo-phase-ii-evaluating-neoadjuvant-oz0c0akcfofz.html"  
[X Link](https://x.com/MarcJacksonLA/status/1980276905841734038)  2025-10-20T14:16Z [----] followers, [---] engagements


"$TYL -Baird lowers Tyler Technologies target to $660 from $720 Outperform -Evercore to $575 from $595 In-Line -DA Davidson to $540 from $560 Neutral - $U -BTIG upgrades Unity to Neutral from Sell - $UPBD -Cowen lowers Unbound target to $31 from $36 Buy -BTIG to $28 from $40 Buy - https://twitter.com/i/web/status/1985183681238225268 https://twitter.com/i/web/status/1985183681238225268"  
[X Link](https://x.com/MarcJacksonLA/status/1985183681238225268)  2025-11-03T03:14Z [----] followers, [---] engagements


"$COLL -Truist raises Collegium Pharmaceuticals target to $48 from $45 Buy -HC Wainwright to $46 from $4 Buy - $COP -JPMorgan lowers ConocoPhillips target to $112 from $115 Overweight - $COR -UBS raises Cencora target to $415 from $380 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1987224020996313166)  2025-11-08T18:21Z [----] followers, [---] engagements


"$DCBO -Needham lowers Docebo target to $38 from $42 Buy - $DD -Wells Fargo lowers Dupont target to $50 from $100 Overweight -Citi raises target to $47 from $38 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1987227782406169001)  2025-11-08T18:36Z [----] followers, [---] engagements


"$GOOS -Evercore raises Canada Goose target to $12 from $11 In-Line -UBS lifts target to $12 from $11 Neutral - $GWW -Barclays raises WW Grainger target to $975 from $963 Underweight - $H -Barclays raises Hyatt Hotels target to $161 fro $156 =nWeight -"  
[X Link](https://x.com/MarcJacksonLA/status/1987293280795828667)  2025-11-08T22:56Z [----] followers, [---] engagements


"$PRTA -HC Wainwright raises Prothena target to $30from $20 Buy -RBC lifts target to $11 from $10 Sector Perform - $PRVA -Citizens JMP raises Privia Health target to $31 from $30 Market Outperform -Evercore lifts target to $30 from $28 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1987657836105732274)  2025-11-09T23:05Z [----] followers, [---] engagements


"$QGEN $MYGN QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP [----] - QIAsymphony Connect the next generation of automated nucleic acid purification platform to be shown at AMP [----] as early access phase begins ahead of full release in mid-2026 - QIAGEN showcases Sample to Insight workflows for comprehensive genomic profiling (CGP) based on Element Biosciences Trinity technology - Partnership with Myriad Genetics to highlight development of a homologous recombination deficiency (HRD) assay for use in cancer profiling"  
[X Link](https://x.com/MarcJacksonLA/status/1987781032435982376)  2025-11-10T07:15Z [----] followers, [---] engagements


"$TMCI -Truist lowers Treace Medical target to $4 from $7 Hold - $TNDM -Barclays raises Tandem Diabetes Care target to $55 from $50 Overweight -Morgan Stanley to $17 from $13 = Weight -Truist to $17 from $16 Hold - $TNYA -Chardan Capital maintains Tenaya Therapeutics $9 target Buy - https://twitter.com/i/web/status/1988068457154519383 https://twitter.com/i/web/status/1988068457154519383"  
[X Link](https://x.com/MarcJacksonLA/status/1988068457154519383)  2025-11-11T02:17Z [----] followers, [---] engagements


"$ZBH -Canaccord lowers Zimmer Biomet target to $93 from $101 Hold - $ZD -UBS lowers Ziff Davis target to $38 from $40 Neutral -Citi to $35 from $42 Neutral -Barclays to $34 from $40 = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/1988074174263554494)  2025-11-11T02:39Z [----] followers, [---] engagements


"$MGTX -Chardan Capital reiterates MeiraGTX $35 target Buy -Piper Sandler raises target to $30 from $28 Overweight - $MIDD -Barclays lowers Middleby target to $168 from $180 Overweight - $MLM -JPMorgan raises Martin Marietta target to $700 from $670 Overweight -Stifel to $681 from $637 Buy - https://twitter.com/i/web/status/1988309274226029020 https://twitter.com/i/web/status/1988309274226029020"  
[X Link](https://x.com/MarcJacksonLA/status/1988309274226029020)  2025-11-11T18:14Z [----] followers, [---] engagements


"$VSAT -JPMorgan raises Viasat target to $50 from $23 Upgrades to Overweight from Neutral -Needham raises target to $45 from $25 Buy - $VYGR -Wedbush maintains Voyager Therapeutics $8 target Outperform - $WAY -Needham initiates Waystar coverage at Buy $46 target -"  
[X Link](https://x.com/MarcJacksonLA/status/1988367648842018841)  2025-11-11T22:06Z [----] followers, [---] engagements


"$PVLA -Canaccord raises Palvella Therapeutics target to $148 from $90 Buy -Chardan Capital maintains $110 target Buy - $PYPD -Roth lowers PolyPid target to $9 from $10 Buy - $RAMP -Morgan Stanley raises Live Ramp target to $33 from $30 = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/1989108484521226357)  2025-11-13T23:09Z [----] followers, [---] engagements


"$AVDL Avadel Receives Unsolicited Proposal from Lundbeck Avadel received an unsolicited proposal from H. Lundbeck A/S to acquire Avadel for up to $23.00 per share$21.00 cash at closing plus a non-transferable CVR worth up to $2.00 tied to U.S. net sales milestones for LUMRYZ and valiloxybate by [----] and [----]. Avadel noted the Lundbeck Proposal is subject to shareholder and regulatory approvals and closing conditions. The Avadel Board determined in good faith the Lundbeck Proposal would reasonably be expected to result in a Company Superior Proposal under its agreement with Alkermes permitting"  
[X Link](https://x.com/MarcJacksonLA/status/1989356025917718714)  2025-11-14T15:33Z [----] followers, [---] engagements


"$HURN -Truist raises Huron target to $240 from $180 Buy - $HWM -Bank of America raises Howmet Aerospace target to $250 from $215 Buy - $IMUX -HC Wainwright lowers Immunic target to $8 from $10 Buy - $INO -Piper Sandler raises Inovio Pharmaceuticals target to $6 from $5 Overweight"  
[X Link](https://x.com/MarcJacksonLA/status/1989786843890815134)  2025-11-15T20:05Z [----] followers, [---] engagements


"$EXPO -William Blair upgrades Exponent to Outperform from Market Perform on strong Q3 results https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868 https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868"  
[X Link](https://x.com/MarcJacksonLA/status/1990499451304357941)  2025-11-17T19:17Z [----] followers, [---] engagements


"$NKE -JPMorgan lowers NIKE target to $86 from $100 Overweight - $NMRA -Stifel raises Neumora Therapeutics target to $3 from $2 Hold - $NP -Morgan Stanley raises Neptune Insurance target to $27 from $26 = Weight - $NRXP -D. Boral maintains NRX Pharmaceuticals $34 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1990548103800537232)  2025-11-17T22:30Z [----] followers, [---] engagements


"$RCKT -Barclays lowers Rocket Pharmaceuticals target to $8 from $10 = Weight -JPMorgan downgrades to Underweight from Neutal - $RCL -Wells Fargo initiates Royal Caribbean coverage at Overweight $320 target - $REG -Barclays lowers Regency Centers target to $82 from $83 Upgrades to Overweight from = Weight -Truist lowers target to $77 from $81 Buy - https://twitter.com/i/web/status/1990964078999974003 https://twitter.com/i/web/status/1990964078999974003"  
[X Link](https://x.com/MarcJacksonLA/status/1990964078999974003)  2025-11-19T02:03Z [----] followers, [---] engagements


"$TEAM -Bernstein raises Atlassian target to $304 from $290 Outperform - $TELA -Canaccord lowers TELA Bio target to $4 from $7 Buy - $TERN -BMO raises Terns Pharmaceuticals target to $30 from $22 Outperform - $TKO -BTIG reiterates TKO Group $235 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1990970081023832549)  2025-11-19T02:27Z [----] followers, [---] engagements


"$AN -Evercore raises AutoNation target to $300 from $240 Outperform - $ANAB -HC Wainwright lowers AnaptysBio target to $51 from $52 Buy -Wedbush maintains $50 target Outperform - $APA -Raymond James reiterates APA $31 target Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1993011217414475966)  2025-11-24T17:37Z [----] followers, [---] engagements


"$LSPD Lightspeed Commerce Unveils Tempo a New Pacing Intelligence for Restaurants Lightspeed's Tempo is a pacing intelligence built into Lightspeed Restaurant that uses real-time dining flow data to guide servers and managers through service moments. Tempo aims to make pacing measurable and coachable to improve guest experience increase table turns and boost staff performance. The product is available to Lightspeed Restaurant customers and will expand connectivity with Lightspeed systems such as Kitchen Display and Pulse."  
[X Link](https://x.com/MarcJacksonLA/status/1993013687821779457)  2025-11-24T17:47Z [----] followers, [---] engagements


"$BNTC -HC Wainwright lowers Benitec Biopharma target to $32 from $35 Buy - $BRBR -Mizuho lowers BellRing Brands target to $40 from $45 Outperform - $BWA -Evercore raises BorgWarner target to $53 from $50 Outperform - $C -UBS maintains Citigroup $108 target Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/1993086491246076358)  2025-11-24T22:37Z [----] followers, [---] engagements


"$IMA -Wedbush assumes Imagene Bio coverage at Underperform $2 target - $IMAX -Goldman raises IMAX target to $34 from $22 Upgrades to Neutral from Sell - $INSP -Wolfe Research upgrades Inspire Medical Systems to Outperform from Peer Perform $180 target - $INVH -Barclays lowers Invitation Homes target to $34 from $37 Overweight - https://twitter.com/i/web/status/1993430827204780455 https://twitter.com/i/web/status/1993430827204780455"  
[X Link](https://x.com/MarcJacksonLA/status/1993430827204780455)  2025-11-25T21:25Z [----] followers, [---] engagements


"$WMG -Goldman lifts Warner Music Group target to $32 from $31 Neutral - $WT -Goldman lowers WisdomTree target to $13.25 from $14.75 Neutral - $WWD -UBS raises Woodward target to $329 from $303 Buy -Truist lifts target to $305 from $294 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1993486870836318440)  2025-11-26T01:08Z [----] followers, [---] engagements


"$BLLN -Analysts initiate Billiontoone coverage -BTIG Buy $160 target -JPMorgan Piper Sandler Overweight $150 target -Stifel Buy $145 target -William Blair Outperform -Jefferies Hold $117 target -Wells Fargo = Weight $110 target -"  
[X Link](https://x.com/MarcJacksonLA/status/1995542025836581351)  2025-12-01T17:14Z [----] followers, [---] engagements


"$CDNS -Oppenheimer lifts Cadence Design target to $275 from $225 Upgrades to Market Perform from Underperform - $CDRO -Benchmark maintains Codere Online at Hold - $CEVA -Loop Capital starts CEVA coverage at Buy $28 target - $CFG -Cowen maintains Citizens Financial $75 target Buy"  
[X Link](https://x.com/MarcJacksonLA/status/1995554878610178293)  2025-12-01T18:05Z [----] followers, [---] engagements


"$EVMN -Analysts initiate Evommune coverage -Leerink Outperform $42 target -Evercore Outperform $40 target -Morgan Stanley Overweight $36 target -Cantor Fitzgerald Overweight -William Blair Outperform - $FAT -Noble Financial downgrades FAT Brands to Market Perform from Outperform - https://twitter.com/i/web/status/1995561202781724913 https://twitter.com/i/web/status/1995561202781724913"  
[X Link](https://x.com/MarcJacksonLA/status/1995561202781724913)  2025-12-01T18:30Z [----] followers, [---] engagements


"$PK -Wells Fargo lowers Park Hotels target to $11 from $12 = Weight - $PMN -HC Wainwright raises Promis Neurosciences target to $18 from $4 Buy - $POST -Mizuho lowers Post target to $120 from $122 Outperform - $PRAX -Needham reiterates Praxis Precision Medicines $250 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1995626861846823142)  2025-12-01T22:51Z [----] followers, [---] engagements


"$PRTA -Citizens JMP raises Prothena target to $19 from $11 Market Outperform - $PSA -Evercore lowers Public Storage target to $309 from $315 In-Line - $PSIX -Jefferies intiates Power Solutions coverage at Buy $110.51 target https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925 https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925"  
[X Link](https://x.com/MarcJacksonLA/status/1995627768567267390)  2025-12-01T22:55Z [----] followers, [---] engagements


"$PTCT -RBC raises PTC Therapeutics target to $91 from $82 Downgrades to Sector Perform from Outperform - $RBRK -Guggenheim reiterates Rubrik $108 target Buy - $RCI -Cowen maintains Rogers Communications $64 target Buy - $RCL -Wells Fargo lowers Royal Caribbean target to $316 from $320 Overweight - https://twitter.com/i/web/status/1995628754924962234 https://twitter.com/i/web/status/1995628754924962234"  
[X Link](https://x.com/MarcJacksonLA/status/1995628754924962234)  2025-12-01T22:59Z [----] followers, [---] engagements


"$MH -BTIG raises McGraw Hill target to $22 from $19 Buy - $MRK -Goldman raises Merck & Co. target to $120 from $92 Buy - $MTD -Morgan Stanley initiates Mettler-Toledo coverage at = Weight $1550 target - $MU -Wolfe Research raises Micron target to $300 from $200 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1995991804718842027)  2025-12-02T23:01Z [----] followers, [---] engagements


"$BFRI Biofrontera Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz-PDT - sNDA for treatment of sBCC with Ameluz-PDT submitted to U.S. Food and Drug Administration (FDA) on November [--] [----] - First Phase [--] PDT study in patients with sBCC in the United States submitted to FDA - Primary and key secondary endpoints met with high statistical significance (p 0.0001) - Favorable recurrence outcomes at one-year follow-up - BCC is the most common skin cancer in the US with more than [--] million cases diagnosed annually"  
[X Link](https://x.com/MarcJacksonLA/status/1995993662468358561)  2025-12-02T23:09Z [----] followers, [---] engagements


"$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html"  
[X Link](https://x.com/MarcJacksonLA/status/1996234881559601170)  2025-12-03T15:07Z [----] followers, [---] engagements


"$ADCT ADC slides on latest Zynlonta update - Deteriorating efficacy and a treatment-related death with Zynlonta plus Columvi spook investors https://www.oncologypipeline.com/apexonco/adc-slides-latest-zynlonta-update https://www.oncologypipeline.com/apexonco/adc-slides-latest-zynlonta-update"  
[X Link](https://x.com/MarcJacksonLA/status/1996265052291404059)  2025-12-03T17:07Z [----] followers, [---] engagements


"$NBP NovaBridge Announces Presentation of Ragistomig Expanded Phase [--] Data at ESMO-IO - Ragistomig is a 4-1BB X PD-L1 bispecific antibody designed to treat patients who are relapsed or refractory to checkpoint inhibitors a multi-billion dollar drug class hampered by widespread resistance - Phase [--] ragistomig study achieved its objective as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders with an improved safety profile - The interim results including immunological data on CD8+ cell proliferation and memory T-cell activation are expected to be"  
[X Link](https://x.com/MarcJacksonLA/status/1996445291160260715)  2025-12-04T05:03Z [----] followers, [---] engagements


"$DTCX $TZUP Thumzup Media Corporation Plans Name Change to Datacentrex Inc. https://www.stocktitan.net/news/DTCX/thumzup-media-corporation-plans-name-change-to-datacentrex-a4a4ftap55a5.html https://www.stocktitan.net/news/DTCX/thumzup-media-corporation-plans-name-change-to-datacentrex-a4a4ftap55a5.html"  
[X Link](https://x.com/MarcJacksonLA/status/1996599862620573836)  2025-12-04T15:17Z [----] followers, [---] engagements


"$MAR -Truist raises Marriott International target to $283 from $278 Hold - $MASI -BTIG raises Masimo target to $200 from $198 Buy - $MAZE -Wells Fargo initiates Maze Therapeutics coverage at Overweight $55 target https://www.investing.com/news/analyst-ratings/maze-therapeutics-stock-rating-initiated-at-overweight-by-wells-fargo-93CH-4390481 https://www.investing.com/news/analyst-ratings/maze-therapeutics-stock-rating-initiated-at-overweight-by-wells-fargo-93CH-4390481"  
[X Link](https://x.com/MarcJacksonLA/status/1996788750559621581)  2025-12-05T03:48Z [----] followers, [---] engagements


"$REGN -Canaccord raises Regeneron target to $1057 from $850 Buy -BMO raises target to $850 from $725 Outperform - $REXR -Mizuho lifts Rexford Industrial target to $41 from $40 Neutral - $RHP -Truist raises Ryman Hospitality target to $121 from $120 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1996806347539861638)  2025-12-05T04:58Z [----] followers, [---] engagements


"$ORIC $AVBP $BDTX $BAYRY ESMO Asia [----] Orics first-line gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble"  
[X Link](https://x.com/MarcJacksonLA/status/1996951858582057231)  2025-12-05T14:36Z [----] followers, [---] engagements


"$AGX -Lake Street lifts Argan target to $325 from $260 Downgrades to Hold from Buy - $AIG -Barclays lowers American International Group target to $88 from $95 Downgrades to = Weight from Overweight - $AJG -Wells Fargo lowers Arthur J. Gallagher target to $344 from $362 Overweight"  
[X Link](https://x.com/MarcJacksonLA/status/1996990655311294538)  2025-12-05T17:10Z [----] followers, [---] engagements


"$RHI -BNP Paribas downgrades Robert Half to Underperform from Neutral $22 target - $RNR -BMO raises RenaissanceRe target to $303 from $294 Outperform - $ROL -Barclays raises Rollins target to $72 from $60 Upgrades to Overweight from = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/1997446639800504367)  2025-12-06T23:22Z [----] followers, [---] engagements


"$VERA -Cowen raises Vera Therapeutics target to $73 from $60 Buy - $VITL -Needham initiates Vital Farms coverage with a Buy rating $45 target - $VRTX -Morgan Stanley raises Vertex Pharmaceuticals target to $564 from $516 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/1997466871243891199)  2025-12-07T00:43Z [----] followers, [---] engagements


"$EVO $SDZNY Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz - Agreement includes approximately US $350m in cash for Just - Evotec Biologics manufacturing site in Toulouse and upfront technology license fees to Evotec's continuous manufacturing platform - Evotec also eligible for license fees and development revenues including success-based milestones adding up to more than US $300m over the coming yearsreplacing existing contractual commitments - Transaction covering royalties on a portfolio ofup to ten biosimilars in technical and early development targeting more than"  
[X Link](https://x.com/MarcJacksonLA/status/1997920507329647049)  2025-12-08T06:45Z [----] followers, [---] engagements


"$APTV -Morgan Stanley raises Aptiv target to $84 from $60 Upgrades to = Weight from Underweight - $AR -JPMorgan lowers Antero Resources target to $39 from $44 Downgrades to Neutral from Overweight - $ARGX -JPMorgan raises argenx target to $1100 from $925 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/1998077845609021654)  2025-12-08T17:10Z [----] followers, [---] engagements


"$FVR -Morgan Stanley raises FrontView REIT target to $17 from $15 = Weight - $GEN -Benchmark reiterates Genius Sports $16 target Buy - $GLTO -Guggenheim raises Alecto target to $36 from $32 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1998145953833107703)  2025-12-08T21:41Z [----] followers, [---] engagements


"$LYEL -HC Wainwright raises Lyell Immunopharma target to $45 from $20 Upgrades to Buy from Neutral - $LYFT -Wells Fargo lifts Lyft target to $26 from $20 = Weight - $MAIN -RBC trims Main Street Capital target to $66 from $67 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1998526265482154439)  2025-12-09T22:52Z [----] followers, [---] engagements


"$TEVA -Barclays initiates Teva Pharmaceutical coverage at Overweight $35 target -Bank of America raises target to $32 from $29 Buy - $TFX -Needham maintains Teleflex Hold rating - $TGT -Evercore lowers Target target to $95 fro $100 In-Line -"  
[X Link](https://x.com/MarcJacksonLA/status/1998557613618008336)  2025-12-10T00:57Z [----] followers, [---] engagements


"$CNM -Baird raises Core & Main target to $64 from $62 Outperform -JPMorgan to $59 from $58 Overweight -Wells Fargo to $57 from $55 Overweight - $CNTA -Oppenheimer raises Centessa Pharmaceuticals target to $62 from $40 Outperform - $COF -Jefferies raises CapitalOne target to $275 from $265 Buy - https://twitter.com/i/web/status/1998816114546192458 https://twitter.com/i/web/status/1998816114546192458"  
[X Link](https://x.com/MarcJacksonLA/status/1998816114546192458)  2025-12-10T18:04Z [----] followers, [---] engagements


"$NPCE -JPMorgan raises NeuroPace target to $20 from $18 Overweight - $NRIX -HC Wainwright raises Nurix Therapeutics target to $31 from $28 Buy -Mizuho lifts target to $30 from $24 Outperform - $NUE -Jefferies raises Nucor target to $190 from $170 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/1998890003297165321)  2025-12-10T22:58Z [----] followers, [---] engagements


"$VALE -RBC raises Vale target to $14.20 from $11 Upgrades to Outperform from Sector Perform - $VLTO -Jefferies lowers Veralto target to $105 from $125 Downgrades to Hold from Buy - $VRDN -Wedbush raises Viridian Therapeutics target to $47 from $42 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1998920682512806131)  2025-12-11T01:00Z [----] followers, [---] engagements


"$TNYA Tenaya Therapeutics Reports Positive Interim Data from Cohort [--] of RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC - Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week [--] - Clinically Meaningful Reductions in Arrhythmia Burden Observed in First Two Patients with More Than Six Months of Follow-Up - Tenaya Management to Host a Webcast Conference Call Thursday December [--] at 5:00 pm ET to Review Preliminary Results"  
[X Link](https://x.com/MarcJacksonLA/status/1999224051391455236)  2025-12-11T21:05Z [----] followers, [---] engagements


"$IKT -Cantor Fitzgerald initiates Inhibikase Therapeutics coverage at Overweight $4 target - $INSM -Cowen raises Insmed target to $269 from $231 Buy - $IONQ -Mizuho initiates IonQ coverage at Outperform $90 target https://www.investing.com/news/analyst-ratings/ionq-stock-initiated-at-outperform-by-mizuho-with-90-price-target-93CH-4402619 https://www.investing.com/news/analyst-ratings/ionq-stock-initiated-at-outperform-by-mizuho-with-90-price-target-93CH-4402619"  
[X Link](https://x.com/MarcJacksonLA/status/1999245254931968055)  2025-12-11T22:29Z [----] followers, [---] engagements


"$LBRX -Stifel raises LB Pharmaceuticals target to $35 from $27 Buy - $LEG -Piper Sandler lifts Leggett & Platt target to $12 from $10 Neutral - $LII -Barclays lowers Lennox target to $680 from $700 Overweight - $LNG -Bank of America lowers Cheniere Energy target to $271 from $274 Buy https://twitter.com/i/web/status/1999253954048512060 https://twitter.com/i/web/status/1999253954048512060"  
[X Link](https://x.com/MarcJacksonLA/status/1999253954048512060)  2025-12-11T23:04Z [----] followers, [---] engagements


"$TNYA Tenaya Therapeutics Announces Pricing of Public Offering The offering is comprised of [--------] units at a public offering price of $1.20 per unit with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $1.50 per share. https://www.stocktitan.net/news/TNYA/tenaya-therapeutics-announces-pricing-of-public-es028g28ab9v.html https://www.stocktitan.net/news/TNYA/tenaya-therapeutics-announces-pricing-of-public-es028g28ab9v.html"  
[X Link](https://x.com/MarcJacksonLA/status/1999372985246056559)  2025-12-12T06:57Z [----] followers, [---] engagements


"$MCS -Barrington Research maintains Marcus $25 target Outperform - $MGY -Mizuho upgrades Magnolia Oil to Outperform from Neutral Raises target to $29 from $26 - $MNST -Stifel raises Monster Beverage target to $82 from $78 Buy - $MPC -Mizuho raises Marathon Petroleum target to $196 from $188 Neutral - https://twitter.com/i/web/status/2000013493123330058 https://twitter.com/i/web/status/2000013493123330058"  
[X Link](https://x.com/MarcJacksonLA/status/2000013493123330058)  2025-12-14T01:22Z [----] followers, [---] engagements


"$NOG -Mizuho raises Northern Oil target to $30 from $28 Neutral - $NTSK -KeyBanc raises Netskope target to $28 from $27 Overweight -Piper Sandler reiterates $28 target Overweight -RBC raises target to $27 from $26 Outperform -Deutsche Bank to $26 from $25 Buy -Mizuho to $26 from $25 Outperform - https://twitter.com/i/web/status/2000019704149315678 https://twitter.com/i/web/status/2000019704149315678"  
[X Link](https://x.com/MarcJacksonLA/status/2000019704149315678)  2025-12-14T01:47Z [----] followers, [---] engagements


"$PNW -KeyBanc downgrades Pinacle West Capital to Sector Weight from Overweight - $POR -JPMorgan raises Portland General Electrictarget to $49 from $47 Neutral - $PPL -Wells Fargo raises PPL target to $45 from $43 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2000233270777413795)  2025-12-14T15:55Z [----] followers, [---] engagements


"$RHI -Truist lowers Robert Half target to $35 from $50 Buy - $RIVN -Needham raises Rivian target to $23 from $14 Buy -Goldman lifts target to $16 from $13 Neutral - $RL -Jefferies raises Ralph Lauren target to $425 from $385 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2000240750865666413)  2025-12-14T16:25Z [----] followers, [---] engagements


"$RLAY -Wells Fargo upgrades Relay Therapeutics to Overweight from = Weight Raises target to $13 from $6 - $RMD -UBS raises ResMed target to $345 from $335 Buy - $ROIV -HC Wainwright raises Roivant Sciences target to $26 from $23 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2000241544079765920)  2025-12-14T16:28Z [----] followers, [---] engagements


"$WSO -KeyBanc maintains Watsco Sector Weight rating - $WTS -Jefferies initiates Watts Water Technologies coverage at Hold $300 target - $WTW -Keefe Bruyette & Woods raises Willis Towers Watson target to $375 from $373 Outperform -Wells Fargo lowers target to$356 from$362 Overweight - https://twitter.com/i/web/status/2000254464796840268 https://twitter.com/i/web/status/2000254464796840268"  
[X Link](https://x.com/MarcJacksonLA/status/2000254464796840268)  2025-12-14T17:20Z [----] followers, [---] engagements


"$LMRI Lumexa Imaging tallies $462.5M in IPO doubling original target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target"  
[X Link](https://x.com/MarcJacksonLA/status/2000597035083567374)  2025-12-15T16:01Z [----] followers, [---] engagements


"$EVTL -Needham raises Vertical Aerospace to $11 from $9 Buy - $EXPO -UBS raises Exponent target to $81 from $76 Neutral - $FAST -Jefferies raises Fastenal target to $52 from $45 Upgrades to Buy from Hold -UBS lifts target to $52 from $45 Upgrades to Buy from Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/2000664680562331842)  2025-12-15T20:30Z [----] followers, [---] engagements


"$GOLF -JPMorgan raises Acushnet target to $474 from $67 Underweight - $GSBD -Lucid Capital initiates Goldman Sachs BDC coverage with a Neutral rating $10.50 target - $GTM -KeyBanc upgrades ZoomInfo Technologies to Sector Weight from Underweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2000691227662889376)  2025-12-15T22:15Z [----] followers, [---] engagements


"$MRK -Bank of America raises Merck & Co. target to $120 from $105 Buy - $MRVI -Wells Fargo raises Maravai Life Sciences target to $4.50 from $4 Overweight - $MSFT -Wolfe Research lowers Microsoft target to $625 from $675 Outperform - $MSGE $MSGS -Wolfe Research downgrades Madison Square Garden Entertainment and Madison Square Sports to Peer Perform from Outperform - https://twitter.com/i/web/status/2000738330187796951 https://twitter.com/i/web/status/2000738330187796951"  
[X Link](https://x.com/MarcJacksonLA/status/2000738330187796951)  2025-12-16T01:22Z [----] followers, [---] engagements


"$POOL -Wells Fargo lowers Pool target to $250 from $320 = Weight - $PRAX -Oppenheimer raises Praxis Precision Medicines target to $750 from $250 Outperform - $PRGO -JPMorgan lowers Perrigo target to $18 from $20 Neutral - $PRI -Morgan Stanley lowers Primerica target to $292 from $301 = Weight - https://twitter.com/i/web/status/2000746388553130323 https://twitter.com/i/web/status/2000746388553130323"  
[X Link](https://x.com/MarcJacksonLA/status/2000746388553130323)  2025-12-16T01:54Z [----] followers, [---] engagements


"$SCCO -Morgan Stanley raises Southern Copper target to $138 from $130 Downgrades to Underweight from = Weight - $SDGR -Bank of America upgrades Schrodinger to Buy from Neutral as company refocuses business strategy on software operations https://www.investing.com/news/analyst-ratings/bofa-securities-upgrades-schrodinger-stock-rating-to-buy-from-neutral-93CH-4408063 https://www.investing.com/news/analyst-ratings/bofa-securities-upgrades-schrodinger-stock-rating-to-buy-from-neutral-93CH-4408063"  
[X Link](https://x.com/MarcJacksonLA/status/2000753122210124001)  2025-12-16T02:21Z [----] followers, [---] engagements


"$INBX Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program - INBRX-106 has enrolled [--] of [--] randomized patients in the Phase [--] portion for first-line unresectable/metastatic HNSCC and expects to finish Phase [--] enrollment in Q1 [----]. - A separate Phase 1/2 checkpoint inhibitor refractory/relapsed NSCLC cohort completed enrollment at [--] patients in November [----]. - Current datasets lack maturity to support conclusions; maturity expected in 2H [----] to inform efficacy versus standard of care. - Ozekibart (INBRX-109)"  
[X Link](https://x.com/MarcJacksonLA/status/2001054728441225514)  2025-12-16T22:19Z [----] followers, [---] engagements


"$CTVA -Goldman raises Corteva target to $78 from $77 Buy - $CUBE -Truist lowers CubeSmart target to $42 from $48 Buy - $CW -Morgan Stanley raises Curtiss-Wright target to $660 from $645 Overweight -Stifel lowers target to $584 from $587 Hold - g"  
[X Link](https://x.com/MarcJacksonLA/status/2001074175981838551)  2025-12-16T23:37Z [----] followers, [---] engagements


"$INSM Wells Fargo raises Insmed target to $234 from $217 Overweight -Cantor Fitzgerald lifts target to $230 from $216 Overweight - $INSP -JPMorgan raises Inspire Medical; Systems target to $118 from $82 Neutral - $INVA -HC Wainwright raises Innoviva target to $46 from $45 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2001094262679855470)  2025-12-17T00:57Z [----] followers, [---] engagements


"$KYMR -RBC raises Kymera Therapeutics target to $103 from $70 Outperform - $KYTX -Wells Fargo raises Kyverna Therapeutics target to $33 from $31 Overweight - $LAMR -Morgan Stanley raises Lamar Advertising target to $140 from $135 = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001105650680828231)  2025-12-17T01:42Z [----] followers, [---] engagements


"$LECO -Stifel lowers Lincoln Electric target to $252 from $265 Hold - $LIF -Canaccord reiterates Life360 $115 target Buy - $LINE -Morgan Stanley lowers Lineage target to $39 from $46 = Weight - $LIVN -Baird lifts LivaNova target to $75 from $70 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2001106169784623342)  2025-12-17T01:44Z [----] followers, [---] engagements


"$MDT -Baird lowers Medtronic target to $103 from $109 Neutral - $MIRM -Stifel raises Mirum Pharmaceuticals target to $98 from $92 Buy - $MIST -Wells Fargo raises Milestone Pharmaceuticals target to $8 from $4 Overweight - $MKSI -Cantor Fitzgerald raises MKS target to $200 from $180 Overweight - https://twitter.com/i/web/status/2001110485417205988 https://twitter.com/i/web/status/2001110485417205988"  
[X Link](https://x.com/MarcJacksonLA/status/2001110485417205988)  2025-12-17T02:01Z [----] followers, [---] engagements


"$PONY -Barclay starts Pony AI coverage with an = Weight rating $15 target - $POOL -Stifel lowers Pool target to $240 from $295 Hold - $PROK -HC Wainwright initiates ProKidney coverage with a Buy rating $12 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2001141594070901122)  2025-12-17T04:05Z [----] followers, [---] engagements


"$ROST -Wells Fargo raises Ross Stores target to $200 from $180 Overweight - $RPD -Jefferies trims Rapid7 target to $18 from $19 Hold - $RSI -Susquehanna lifts Rush Street target to $23 from $22 Positive - $RXO -Stifel lifts RXO target to $16 from $15 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2001152435239444489)  2025-12-17T04:48Z [----] followers, [---] engagements


"$WMT -Evercore raises Walmart target to $120 from $117 Outperform - $WRB -Morgan Stanley lowers W.R. Berkley target to $75 from $80 = Weight - $WRBY -Piper Sandler raises Warby Parker target to $32 from $22 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001165253900701937)  2025-12-17T05:39Z [----] followers, [---] engagements


"$WYFI -Compass Point initiates WhiteFiber coverage with a Buy rating $32 target - $XPO -Stifel raises XPO target to $167 from $149 Buy - $XRAY -Barrington Research lowers Dentsply Sirona target to $14 from $18 Outperform -Baird trims target to $12 from $14 Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/2001166242233860584)  2025-12-17T05:43Z [----] followers, [---] engagements


"$WST West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector via @Barchart https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector"  
[X Link](https://x.com/MarcJacksonLA/status/2001329758450434402)  2025-12-17T16:32Z [----] followers, [---] engagements


"$RCT RedCloud Delivers Record [----] Executes $50m Turkiye License and Accelerates Toward $100m Revenue in [----] https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html"  
[X Link](https://x.com/MarcJacksonLA/status/2001415142861426885)  2025-12-17T22:12Z [----] followers, [---] engagements


"$EQH BMO reiterates Equitable $69 target Outperform - $ES -UBS lowers Eversource Energy target to $73 from $78 Neutral - $ESTA -Mizuho raises Establishment Labs target to $90 from $85 Outperform -Canaccord to $85 from $72 Buy -JPMorgan to $80 from $71 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001431037835120846)  2025-12-17T23:15Z [----] followers, [---] engagements


"$LEGN -Cantor Fitzgerald trims Legend Biotech target to $74 from $75 Overweight - $LEN -RBC downgrades Lennar to Underperform from Sector Perform - $LITE -Morgan Stanley raises Lumentum target to $304 from $190 = Weight - $LIVN -Mizuho raises LivaNova target to $72 from $70 Outperform - https://twitter.com/i/web/status/2001445275098059226 https://twitter.com/i/web/status/2001445275098059226"  
[X Link](https://x.com/MarcJacksonLA/status/2001445275098059226)  2025-12-18T00:11Z [----] followers, [---] engagements


"$SMMT -Barclays raises Summit Therapeutics target to $18 from $16 Upgrades to = Weight from Underweight - $SMWB -Oppenheimer lowers Similarweb target to $10 from $12 Outperform - $SNX -Morgan Stanley lowers TD SYNNEX target to $177 from $181 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001495658281447504)  2025-12-18T03:32Z [----] followers, [---] engagements


"$TDC -Morgan Stanley raises Teradata target to $35 from $30 Overweight - $TEF -New Street downgrades Telefonica to Reduce from Neutral [----] target - $TENX -Guggenheim maintains Tenax Therapeutics $25 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2001500921013113341)  2025-12-18T03:53Z [----] followers, [---] engagements


"$TFC -Morgan Stanley raises Truist Financial target to $56 from $55 = Weight -Keefe Bruyette & Woods lift target to $53 from $49 Market Perform - $TFX -RBC raises Teleflex target to $135 from $120 Sector Perform - $TJX -Baird raises TJX Companies target to $168 from $165 Outperform - https://twitter.com/i/web/status/2001501692404338743 https://twitter.com/i/web/status/2001501692404338743"  
[X Link](https://x.com/MarcJacksonLA/status/2001501692404338743)  2025-12-18T03:56Z [----] followers, [---] engagements


"$ULTA -Baird raises Ulta Beauty target to $700 from $670 Outperform - $UPB -Mizuho starts Upstream Bio coverage at Outperform -Sets $51 target http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html"  
[X Link](https://x.com/MarcJacksonLA/status/2001505165971722567)  2025-12-18T04:09Z [----] followers, [---] engagements


"$WSBC -Piper Sandler initiates WesBanco coverage with an Overweight rating $42 target - $WT -Morgan Stanley raises WisdomTree target to $14.75 from $13.50 = Weight - $WTRG -Barclays downgrades Essential Utilities to Underweight from Overweight Lowers target to $38 from $43 -"  
[X Link](https://x.com/MarcJacksonLA/status/2001522123043672107)  2025-12-18T05:17Z [----] followers, [---] engagements


"$XEL -UBS lowers Xcel Energy target to $81 from $86 Neutral - $XNCR -Barclays raises Xencor target to $26 from $23 Overweight - $YOU -Telsey raises Clear Secure target to $45 from $38 Outperform - $ZYME -Truist reiterates Zymeworks Buy rating $40 target --"  
[X Link](https://x.com/MarcJacksonLA/status/2001522770833014786)  2025-12-18T05:19Z [----] followers, [---] engagements


"$CLYM -HC Wainwright raises Climb Bio target to $11 from $9 Buy - $CMCSA -UBS maintains Comcast $36 target Neutral - $CMI -Truist raises Cummins target to $653 from $628 Buy - $CNK -Morgan Stanley lowers Cinemark target to $28 from $35 Downgrades to = Weight from Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001745111223513176)  2025-12-18T20:03Z [----] followers, [---] engagements


"$CRL -Mizuho raises Charles River Laboratories target to $200 from $174 Neutral - $CRVO -HC Wainwright reiterates CervoMed $25 target Buy -Cantor Fitzgerald initiates coverage with an Overweight rating citing promising data from two Phase [--] studies https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-cervomed-stock-with-overweight-rating-93CH-4414813 https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-cervomed-stock-with-overweight-rating-93CH-4414813"  
[X Link](https://x.com/MarcJacksonLA/status/2001755516796871153)  2025-12-18T20:44Z [----] followers, [---] engagements


"$DAL -Wells Fargo initiates Delta Air Lines coverage at Overweight $87 target - $DBVT -HC Wainwright raises DBV Technologies target to $40 from $35 Buy - $DD -Mizuho raises DuPont target to $46 from $44 Outperform - $DHR -KeyBanc reiterates Danaher $310 target Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001757653765362016)  2025-12-18T20:53Z [----] followers, [---] engagements


"$EMN -Citi raises Eastman Chemical target to $72 from $70 Buy - $EQIX -Goldman lowers Equinix target to $795 from $910 Downgrades to Neutral from Buy - $ETN -Wells Fargo lowers Eaton target to $340 from $395 = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/2001762020698526083)  2025-12-18T21:10Z [----] followers, [---] engagements


"$GBCI -Piper Sandler raises Glacier Bancorp target to $58 from $50 Upgrades to Overweight from Neutral - $GDRX -Morgan Stanley lowers GoodRx target to $4 from $5 = Weight - $GEV -Baird raises GE Verona target to $816 from $706 Outperform -Jefferies lifts target to $815 from $736 Upgrades to buy from Hold - https://twitter.com/i/web/status/2001847642322801063 https://twitter.com/i/web/status/2001847642322801063"  
[X Link](https://x.com/MarcJacksonLA/status/2001847642322801063)  2025-12-19T02:50Z [----] followers, [---] engagements


"$PRCT -Truist lowers PROCEPT BioRobotics target to $47 from $50 Buy - $PSA -JPMorgan lowers Public Storage target to $301 from $316 Downgrades to Neutral from Overweight - $PYXS -RBC lowers Pyxis Oncology target to $5 from $8 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2001888306905456717)  2025-12-19T05:32Z [----] followers, [---] engagements


"$RPM -MIzuho lowers RPM International target to $128 from $138 Outperform -Citi to $127 from $136 Buy -UBS to $119 from $127 Neutral - $RTO -Bank of America raises Rentokil Initial target to $34 from $28 Upgrades to Buy from Neutral - $RYN -RBC lowers Rayonier target to $25 from $27 Sector Perform - https://twitter.com/i/web/status/2001895913451868359 https://twitter.com/i/web/status/2001895913451868359"  
[X Link](https://x.com/MarcJacksonLA/status/2001895913451868359)  2025-12-19T06:02Z [----] followers, [---] engagements


"$WLK -Citi raises Westlake target to $85 from $75 Buy - $ZBRA -Truist lowers Zebra Technologies target to $291 from $331 Hold - $ZS -Morgan Stanley lowers Zscaler target to $305 from $335 Overweight - $ZTS -Morgan Stanley lowers Zoetis target to $160 from $175 Overweight --"  
[X Link](https://x.com/MarcJacksonLA/status/2001903786655367325)  2025-12-19T06:33Z [----] followers, [---] engagements


"$INAB IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager https://www.stocktitan.net/news/INAB/in8bio-announces-pricing-of-private-placement-of-up-to-40-2-million-m0tfyux0ggs5.html https://www.stocktitan.net/news/INAB/in8bio-announces-pricing-of-private-placement-of-up-to-40-2-million-m0tfyux0ggs5.html"  
[X Link](https://x.com/MarcJacksonLA/status/2002047884192338101)  2025-12-19T16:06Z [----] followers, [---] engagements


"$AMPL -Baird lifts Amplitude target to $15 from $14 Outperform - $APD -Wells Fargo lowers Air Products target to $250 from $330 Downgrades to = Weight from Overweight - $APH -Truist raises Amphenol target to $180 from $147 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2002409083932967061)  2025-12-20T16:01Z [----] followers, [---] engagements


"$MLYS -Stifels raises Mineralys Therapeutics target to $52 from $45 Buy - $MNST -Bank of America raises Monster Beverage target to $85 from $77 Buy - $MPWR -Truist raises Monolithic Power target to $1375 from $1163 Buy - $MTDR -KeyBanc maintains Matador Resources $52 target Overweight - https://twitter.com/i/web/status/2002489219076534682 https://twitter.com/i/web/status/2002489219076534682"  
[X Link](https://x.com/MarcJacksonLA/status/2002489219076534682)  2025-12-20T21:20Z [----] followers, [---] engagements


"$TTAM -Bernstein raises Titan America target to $17 from $15 Market Perform - $TTMI -Truist raises TTM Technologies target to $91 from $78 Buy - $TXN -Truist raises Texas Instruments target to $195 from $175 Hold - $UBER -Wedbush lowers Uber target to $78 from $84 Neutral -0"  
[X Link](https://x.com/MarcJacksonLA/status/2002520937577787556)  2025-12-20T23:26Z [----] followers, [---] engagements


"$AVIR Atea Pharmaceuticals Completes Patient Enrollment in North American Phase [--] Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-north-american-wbapc081xczz.html https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-north-american-wbapc081xczz.html"  
[X Link](https://x.com/MarcJacksonLA/status/2003133922532798799)  2025-12-22T16:01Z [----] followers, [---] engagements


"$ACLX -Wells Fargo initiates Arcellx coverage at Overweight viewing company's anito-cel therapy as a 'future pillar in multuple myeloma management' -Sets $100 target https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-coverage-on-arcellx-stock-with-overweight-rating-93CH-4418972 https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-coverage-on-arcellx-stock-with-overweight-rating-93CH-4418972"  
[X Link](https://x.com/MarcJacksonLA/status/2003201876179976358)  2025-12-22T20:31Z [----] followers, [---] engagements


"$ADEA -Roth reiterates Adeia $27 target Buy -Rosenblatt raises target to $20 from $17 Buy - $AFL -Cowen raises Aflac target to $102 from $100 Hold - $AGNC -Piper Sandler raises AGNC Investment target to $11 from $10.50 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2003203759904817199)  2025-12-22T20:39Z [----] followers, [---] engagements


"$FITB -Truistr raises Fifth Third Bank target to $55 from $50 Buy - $FLUT -Truist lowers Flutter Entertainment target to $280 from $305 Buy - $FMC -KeyBanc maintains FMC Sector Weight rating - $FN -Northland raises Fabrinet target to $600 from $550 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2003226447868313967)  2025-12-22T22:09Z [----] followers, [---] engagements


"$LW -Bank of America lowers Lamb Weston target to $53 from $66 Neutral -Stifel to $50 from $63 Hold -Deutsche Bank to $49 from $61 Hold -BNP Paribas to $48 from $66 Downgrades to Neutral from Outperform - $MCK -Cowen reiterates McKesson $1000 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2003250277819060342)  2025-12-22T23:44Z [----] followers, [---] engagements


"$RC -Piper Sandler lowers Ready Capital target to #4.50 from $3.50 Neutral - $REXR -Evercore trims Rexford Industrial target to $40 from $41 In-Line - $RF -Truist raises Regions Financial target to $29 from $26 Hold - $RJF -Morgan Stanley raises Raymond James Financial target to $187 from $185 = Weight - https://twitter.com/i/web/status/2003266424765387164 https://twitter.com/i/web/status/2003266424765387164"  
[X Link](https://x.com/MarcJacksonLA/status/2003266424765387164)  2025-12-23T00:48Z [----] followers, [---] engagements


"$SEE -Raymond James downgrades Sealed Air to Market Perform from Outperform -' $SIGI -Piper Sandler raises Selective Insurance target to $179 from $176 Neutral - $SLGL -HC Wainwright maintains Sol-Del Technologies $50 target Buy - $SMR -B. Riley lowers NuScale Power target to $24 from $38 Buy - https://twitter.com/i/web/status/2003268635465515428 https://twitter.com/i/web/status/2003268635465515428"  
[X Link](https://x.com/MarcJacksonLA/status/2003268635465515428)  2025-12-23T00:57Z [----] followers, [---] engagements


"$OLMA $OPNT [--] people charged in $41M insider trading scheme tied to [--] biotechs https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme"  
[X Link](https://x.com/MarcJacksonLA/status/2003272868076089683)  2025-12-23T01:14Z [----] followers, [---] engagements


"$TEAD -Needham maintains Teads $1 target Buy - $TEM -Canaccord lowers Tempus AI target to $80 from $95 Buy - $TEVA -Piper Sandler raises Teva Pharmaceuticals target to $40 from $30 Overweight - $TFII -RBC raises TFI International target to $125 from $102 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2003278732380041566)  2025-12-23T01:37Z [----] followers, [---] engagements


"$TLX -HC Wainwright maintains Telix Pharmaceuticals $20 target Buy - $TMDX -Piper Sandler reiterates TransMedics $140 target Buy - $TME -Morgan Stanley lowers Tencent Music target to $25 from $27.50 Overweight - $TMUS -Bernstein maintains T-Mobile $265 target Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/2003279329770504573)  2025-12-23T01:39Z [----] followers, [---] engagements


"$WGS -Canaccord lifts GeneDX target to $170 from $160 Buy - $WHWK -Jones Trading initiates Whitehawk Therapeutics with a Buy rating highlighting three antibody drug conjugates in-licensed from WuXi Biologics -Sets $7 target https://www.investing.com/news/analyst-ratings/jones-trading-initiates-coverage-on-whitehawk-therapeutics-stock-with-buy-rating-93CH-4419921 https://www.investing.com/news/analyst-ratings/jones-trading-initiates-coverage-on-whitehawk-therapeutics-stock-with-buy-rating-93CH-4419921"  
[X Link](https://x.com/MarcJacksonLA/status/2003282267670806695)  2025-12-23T01:51Z [----] followers, [---] engagements


"$AME -Cowen raises AMETEK target to $230 from $190 Upgrades to Buy from Hold - $AMPX -Oppenheimer maintains Amprius Technologies $17 target Outperform - $ANNX -Chardan Capital reiterates Annexon $16 target Buy - $ARCB -Bank of America raises ArcBest target to $84 from $72 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2003593484276760659)  2025-12-23T22:28Z [----] followers, [---] engagements


"$CNO -Piper Sandler raises CNO Financial target to $50 from $46 Overweight - $COTY -Santander downgrades Coty to Neutral from Outperform $3.50 target - $COYA -D. Boral maintains Coya Therapeutics $15 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2003597309905633282)  2025-12-23T22:43Z [----] followers, [---] engagements


"$MNST -Morgan Stanley raises Monster Beverage target to $87 from $81 Overweight - $MTN -Morgan Stanley trims Vail Resorts target to $151 from $153 = Weight - $NAVN -Citizens JMP reiterates Navan $25 target Market Outperform - $NICE -Rosenblatt maintains NiCE $175 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2003606925368525295)  2025-12-23T23:21Z [----] followers, [---] engagements


"$WGO -Benchmark raises Winnebago target to $48 from $42 Buy - $WLK -UBS trims Westlake target to $92 from $93 Overweight - $WSM -Evercore raises Williams Sonoma target to $195 from $190 In-Line --"  
[X Link](https://x.com/MarcJacksonLA/status/2003615786607493594)  2025-12-23T23:56Z [----] followers, [---] engagements


"$DOMO -Cantor Fitzgerald reiterates Domo $22 target Overweight - $DTE -BMO lowers DTE Energy target to $148 from $151 Market Perform - $EOLS -Needham maintains Evolus Hold rating - $EPM -Freedom Capital initiates Evolution Petroleum with a Buy rating $5.30 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2003889266666156345)  2025-12-24T18:03Z [----] followers, [---] engagements


"$ICCC ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain ImmuCell pauses further internal investment in ReTain after an FDA Incomplete Letter and redirects resources to the First Defense franchise. The company expects a noncash impairment of about $2.3M against ReTain assets with a $15.5M net book value while expanding sales and manufacturing for First Defense. https://www.stocktitan.net/news/ICCC/immu-cell-announces-strategic-focus-on-first-defense-after-receiving-rf7gftwv4t14.html"  
[X Link](https://x.com/MarcJacksonLA/status/2003917434567446929)  2025-12-24T19:55Z [----] followers, [---] engagements


"$CELH $GURU $MNST $PEP $STBFY Best Energy Drink Stocks WarrenAI Says to Buy for 2026: From Monster to Celsius https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709 https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709"  
[X Link](https://x.com/MarcJacksonLA/status/2003969697499492642)  2025-12-24T23:23Z [----] followers, [---] engagements


"$IKT -HC Wainwright assumes Inhibikase coverage with a Buy rating as company plans to advance its lead candidate IKT-001 -Sets $8 target https://www.investing.com/news/analyst-ratings/hc-wainwright-assumes-coverage-on-inhibikase-stock-with-buy-rating-93CH-4423069 https://www.investing.com/news/analyst-ratings/hc-wainwright-assumes-coverage-on-inhibikase-stock-with-buy-rating-93CH-4423069"  
[X Link](https://x.com/MarcJacksonLA/status/2004709460120596579)  2025-12-27T00:22Z [----] followers, [---] engagements


"$RPRX $RHHBY Royalty Pharma Acquires Remaining Royalty Interest in Roches Evrysdi for $240 Million and Potential Milestones Evrysdi marketed by Roche is an orally administered survival motor neuron-2 (SMN2) splicing modifier for the treatment of spinal muscular atrophy. Evrysdi was approved by the FDA in [----] and has treated over [-----] patients worldwide. In [----] Evrysdi generated sales of approximately CHF [---] billion ($1.9 billion) representing 18% year-over-year growth at constant exchange rates and is projected to reach CHF [---] billion ($2.9 billion) of sales by [----] based on analyst"  
[X Link](https://x.com/MarcJacksonLA/status/2005815056508817776)  2025-12-30T01:35Z [----] followers, [---] engagements


"$BMR Beamr Completes SOC [--] Audit Reinforcing Enterprise-Grade Security and Privacy Operations https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html"  
[X Link](https://x.com/MarcJacksonLA/status/2006021021271257430)  2025-12-30T15:14Z [----] followers, [---] engagements


"$AAON -William Blair reiterates AAON Outperform rating - $AFL -Raymond James raises Aflac target to $119 from $110 Outperform - $AIRE -HC Wainwright maintains reAlpha Tech $2 target Buy https://www.investing.com/news/analyst-ratings/realpha-tech-stock-maintains-buy-rating-at-hc-wainwright-following-instamortgage-acquisition-93CH-4425241 https://www.investing.com/news/analyst-ratings/realpha-tech-stock-maintains-buy-rating-at-hc-wainwright-following-instamortgage-acquisition-93CH-4425241"  
[X Link](https://x.com/MarcJacksonLA/status/2006148492389929035)  2025-12-30T23:40Z [----] followers, [---] engagements


"$CVLT -Stephens initiates CommVault coverage with an Overweight rating $162 target - $DECK -UBS maintains Deckers Outdoor $157 target Buy - $DNLI -Jefferies maintains Denali Therapeutics $40 target Buy - $DRUG -HC Wainwright reiterates Bright Minds Biosciences $115 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2006152733523415238)  2025-12-30T23:57Z [----] followers, [---] engagements


"$TWLO -Citizens JMP raises Twilio target to $185 from $165 Market Outperform - $UNCY -Guggenheim reiterates Unicycive Buy rating amid NDA resubmission -Maintains $46 target https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234 https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234"  
[X Link](https://x.com/MarcJacksonLA/status/2006166315933770192)  2025-12-31T00:51Z [----] followers, [---] engagements


"$WTFC -Citi raises Wintrust Financial target to $167 from $159 Buy - $ZVRA -HC Wainwright maintains Zevra Therapeutics Buy rating on expanded access deal -Maintains $26 target -- https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240 https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240"  
[X Link](https://x.com/MarcJacksonLA/status/2006167915809198473)  2025-12-31T00:57Z [----] followers, [---] engagements


"$WSP -BMO raises WSP Global target to C$336 from C$335 Outperform - $WULF Keefe Bruyette & Woods raise TeraWulf target to $24 from $9.50 Upgrade to Outperform from Market Perform https://stocktwits.com/news-articles/markets/equity/wulf-stock-rises-3-percent-pre-market-after-keefe-more-than-doubles-price-target/cL7B7PaREzF https://stocktwits.com/news-articles/markets/equity/wulf-stock-rises-3-percent-pre-market-after-keefe-more-than-doubles-price-target/cL7B7PaREzF"  
[X Link](https://x.com/MarcJacksonLA/status/2006438730392023081)  2025-12-31T18:54Z [----] followers, [---] engagements


"$AMSC $MGY $PBW $XOP Clear Street Names American Superconductor and Magnolia Oil & Gas as Top [----] Picks https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616 https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616"  
[X Link](https://x.com/MarcJacksonLA/status/2007158852220035314)  2026-01-02T18:35Z [----] followers, [---] engagements


"$ECVT -BWS reiterates Ecovyst $12 target Buy - $ESNT -Roth raises Essent Group target to $75 from $70 Buy - $FBLG -HC Wainwright maintains FibroBiologics $5 target Buy - $GKOS -Stephens raises Glaukos target to $145 from $115 Overweight -BTIG maintains $116 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2007164949920133157)  2026-01-02T18:59Z [----] followers, [---] engagements


"$HOLO MicroCloud Hologram Inc. Launches Q-DPC Accelerator: Quantum-Empowered Density Peak Clustering's Strategy Evaluation Performance Leap Solution https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html"  
[X Link](https://x.com/MarcJacksonLA/status/2007197635434950938)  2026-01-02T21:09Z [----] followers, [---] engagements


"- $A -Evercore upgrades Agilent Technologies to Outperform from In-Line $160 target - $ABT -Barclays raises Abbott target to $169 from $162 Overweight - $ACAD -Needham raises ACADIA Pharmaceuticals target to $34 from $29 Buy - $ACN -Rothschild Redburn raises Accenture target to $210 from $205 Neutral - https://twitter.com/i/web/status/2008229319882207288 https://twitter.com/i/web/status/2008229319882207288"  
[X Link](https://x.com/MarcJacksonLA/status/2008229319882207288)  2026-01-05T17:29Z [----] followers, [---] engagements


"$AIRO -Mizuho lowers AIRO target to $20 from $25 Outperform - $AKAM -RBC raises Akamai target to $90 from $80 Sector Perform -Piper Sandler lifts target to $89 from $86 Neutral - $AKTX -Ladenburg Thalman initiates Akari Therapeutics coverage with a Buy rating $1 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2008230490919317543)  2026-01-05T17:33Z [----] followers, [---] engagements


"$CRAI -Barrington Research raises Charles River target to $245 from $239 Outperform - $CRBG -JPMorgan trims Corebridge Financial target to $39 from $40 Neutral - $CRC -RBC raises California Resources target to $70 from $60 Outperform - $CRCL -Goldman raises Circle Internet target to $88 from $79 Neutral - https://twitter.com/i/web/status/2008274433824436584 https://twitter.com/i/web/status/2008274433824436584"  
[X Link](https://x.com/MarcJacksonLA/status/2008274433824436584)  2026-01-05T20:28Z [----] followers, [---] engagements


"$CSV -Barrington Research reiterates Carriage Services $60 target Outperform - $CVLT -Piper Sandler lowers Commvault target to $155 from $186 Overweight - $CVNA -Gordon Haskett lowers Carvana target to $435 from $445 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2008276318283329835)  2026-01-05T20:36Z [----] followers, [---] engagements


"$CVX -Citi lowers Chevron target to $179 from $185 Buy -Bernstein raises target to $172 from $170 Market Perform - $CYH -Truist trims Community Health Systems target to $4 from $4.50 Hold - $DBX _RBC lowers Dropbox target to $35 from $38 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2008276868576014660)  2026-01-05T20:38Z [----] followers, [---] engagements


"$DMAC -Lake Street initiates DiaMedica Therapeutics coverage with a Buy rating $14 target - $DOC -Cantor lowers Healthpeak Properties target to $17 from $20 Neutral - $DOCN -Piper Sandler raises DigitalOcean target to $50 from $47 Neutral - $DOCU -RBC lowers DocuSign target to $70 from $95 Sector Perform - https://twitter.com/i/web/status/2008278965467951131 https://twitter.com/i/web/status/2008278965467951131"  
[X Link](https://x.com/MarcJacksonLA/status/2008278965467951131)  2026-01-05T20:46Z [----] followers, [---] engagements


"$DPZ -Cowen lowers Domino's Pizza target to $460 from $500 Downgrades to Hold from Buy - $DT -RBC lowers Dynatrace target to $56 from $64 Outperform -Jefferies cuts target to $55 from $65 Buy - $DUOL -Bank of America lowers Duolingo target to $250 from $301 Upgrades to Buy from Neutral - https://twitter.com/i/web/status/2008279624103719387 https://twitter.com/i/web/status/2008279624103719387"  
[X Link](https://x.com/MarcJacksonLA/status/2008279624103719387)  2026-01-05T20:49Z [----] followers, [---] engagements


"$ELV -Barclays raises Elevance Health target to $404 from $385 Overweight - $EMR -UBS raises Emerson Electric target to $168 from $131 Upgrades to Buy from Neutral - $ENOV -UBS lowers Enovis target to $50 from $57 Buy -Evercore cuts target to $40 from $44 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2008281916303114496)  2026-01-05T20:58Z [----] followers, [---] engagements


"$EPC -Wells Fargo lowers Edgewell Personal Care target to $20 from $23 Overweight - $EPD -Raymond James downgrades Enterprise Product Partners to Outperform from Strong Buy $36 target - $EQH -JPMorgan upgrades Equitable to Overweight from Neutral Lowers target to $60 from $64 -"  
[X Link](https://x.com/MarcJacksonLA/status/2008334261472854034)  2026-01-06T00:26Z [----] followers, [---] engagements


"$EQT -Bernstein lifts EQT target to $73 from $72 Outperform - $ESTC -RBC lowers Elastic target to $95 from $115 Outperform -Jefferies cuts target to $95 from $105 Buy - $ETOR -Goldman lowers eToro target to $39 from $48 Downgrades to Neutral from Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2008334829675216923)  2026-01-06T00:28Z [----] followers, [---] engagements


"$GTLB -Piper Sandler lowers GitLab target to $55 from $70 Overweight -RBC cuts target to $48 from $58 Outperform - $HBAN -Barclays lifts Huntington Bancshares target to $20 from $19 = Weight - $HESM -Raymond James downgrades Hess Midstream to Market Perform from Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2008346518688879064)  2026-01-06T01:14Z [----] followers, [---] engagements


"$HII -Melius upgrades Huntington Ingalls to Buy from Hold - $HIMS -Citi maintains Hims & Hers Health $30 target Sell - $HNGE -Barclays lowers Hinge Health target to $60 from $65 Overweight - $HOLX -Evercore trims Hologic target to $78 from $79 Downgrades to In-Line from Outperform - https://twitter.com/i/web/status/2008348357165805981 https://twitter.com/i/web/status/2008348357165805981"  
[X Link](https://x.com/MarcJacksonLA/status/2008348357165805981)  2026-01-06T01:22Z [----] followers, [---] engagements


"$MNDY -Jefferies lowers target to $260 from $300 Buy - $MNMD -Needham adds Mind Medicine to Conviction List names stock as a top pick Reiterates Buy rating $28 target - $MNST -Wells Fargo raises Monster Beverage target to $86 from $83 Overweight - http://monday.com http://monday.com"  
[X Link](https://x.com/MarcJacksonLA/status/2008367609629065693)  2026-01-06T02:38Z [----] followers, [---] engagements


"$PNR -Cowen lowers Pentair target to $90 from $110 Downgrades to Sell from Hold - $PRAX -Needham raises Praxis Precision Medicines target to $460 from $315 Buy - $PRDO -Barrington Research reiterates Perdoceo Education $42 target Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2008414577483276506)  2026-01-06T05:45Z [----] followers, [---] engagements


"$RBLX -Wolfe Research lowers Roblox target to $100 from $150 Outperform - $RBRK -Piper Sandler cuts Rubrik target to $99 from $118 Overweight - $REG -Morgan Stanley raises Regency Centers target to $85 from $78 Overweight - $RF -Barclays raises Regions Financial target to $30 from $27 Underweight - https://twitter.com/i/web/status/2008416624223858930 https://twitter.com/i/web/status/2008416624223858930"  
[X Link](https://x.com/MarcJacksonLA/status/2008416624223858930)  2026-01-06T05:53Z [----] followers, [---] engagements


"$RPD -Piper Sandler lowers Rapid7 target to $16 from $19 Neutral -RBC cuts target to $16 from $19 Sector Perform -Barclays lowers target to $15 from $18 Downgrades to Underweight from = Weight - $RSG -Bernstein raises Republic Services target to $220 from $205 Market Perform -"  
[X Link](https://x.com/MarcJacksonLA/status/2008418078221365349)  2026-01-06T05:59Z [----] followers, [---] engagements


"$TCMD -Piper Sandler raises Tactile Medical target to $35 from $20 Upgrades to Overweight from Neutral - $TDC -RBC raises Teradata target to $32 from $23 Sector Perform - $TEAM -Piper Sandler lowers Atlassian target to $280 from $300 Overweight - $TECH -Evercore lowers Bio-Techne target to $62 from $68 Downgrades to In-Line from Outperform - https://twitter.com/i/web/status/2008423776363704519 https://twitter.com/i/web/status/2008423776363704519"  
[X Link](https://x.com/MarcJacksonLA/status/2008423776363704519)  2026-01-06T06:21Z [----] followers, [---] engagements


"$TENB -Piper Sandler lowers Tenable target to $35 from $40 Overweight -Barclays cuts target to $28 from $33 = Weight - $TFC -Barclays raises Truist Financial target to $56 from $47 Downgrades to Underweight from = Weight - $TFII -Susquehanna raises TFI International target to $123 from $105 Positive - https://twitter.com/i/web/status/2008424542121980037 https://twitter.com/i/web/status/2008424542121980037"  
[X Link](https://x.com/MarcJacksonLA/status/2008424542121980037)  2026-01-06T06:25Z [----] followers, [--] engagements


"$TMO -Evercore raises Thermo Fisher target to $650 from $610 Outperform - $TSHA -Wells Fargo raises Taysha Gene Therapies target to $11 from $8 Overweight - $TSM -Goldman raises Taiwan Semiconductor Manufacturing target to NT2330 from NT1720 Buy - $TT -UBS lowers Trane Technologies target to $520 from $544 Buy - https://twitter.com/i/web/status/2008425340620943461 https://twitter.com/i/web/status/2008425340620943461"  
[X Link](https://x.com/MarcJacksonLA/status/2008425340620943461)  2026-01-06T06:28Z [----] followers, [---] engagements


"$UNH -Barclays raises UnitedHealth target to $391 from $386 Overweight - $UNM -Jefferies maintains Unum $115 target Buy - $UPWK -Jefferies raises Upwork target to $27 from $22 Buy - $URGN -D. Boral reiterates Urogen Pharma $33 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2008427347104645304)  2026-01-06T06:36Z [----] followers, [---] engagements


"$USB -Barclays raises US anchor target to $65 from $56 Overweight - $VCYT -Guggenheim raises Veracyte target to $50 from $45 Buy - $VICI -Cantor Fitzgerald lowers VICI properties target to $33 from $35 Overweight - $VNDA -HC Wainwright raises Vanda Pharmaceuticals target to $22 from $20 Buy - https://twitter.com/i/web/status/2008428174313746538 https://twitter.com/i/web/status/2008428174313746538"  
[X Link](https://x.com/MarcJacksonLA/status/2008428174313746538)  2026-01-06T06:39Z [----] followers, [---] engagements


"$ZBH -Evercore raises Zimmer Biomet target to $120 from $94 Upgrades to Outperform from In-Line - $ZBIO -Morgan Stanley cuts Zenas Biopharma target to $19 from $37 Downgrades to = Weight from Overweight - $ZION -Barclays raises Zions Bancorp target to $68 from $61 Underweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2008432866234167617)  2026-01-06T06:58Z [----] followers, [---] engagements


"$ARVN -Citi raises Arvinas target to $15 from $10 Upgrades to Buy from Neutral - $ATR -Wells Fargo downgrades AptarGroup target to = Weight from Overweight $133 target - $AVXL -D. Boral reiterates Anavex Life Sciences $24 target Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2008572393535775171)  2026-01-06T16:12Z [----] followers, [---] engagements


"$ELV -Bernstein raises Elevance Health target to $431 from $412 Outperform - $ENOV -BTIG initiates Enovis coverage at Buy $41 target - $EPAM -Truist starts EPAM Systems coverage at Hold $220 target - $EQIX -Deutsche Bank initiates Equinix coverage at Buy $915 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2008632208030859775)  2026-01-06T20:10Z [----] followers, [---] engagements


"$GHRS -Canaccord raises GH Research target to $39 from $35 Buy -Needham raises target to $29 from $19 Buy - $GL -Evercore downgrades Globe Life to In-Line from Outperform $155 target - $GLOB -Truist initiates Globant coverage at Hold $72 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2008685886817685896)  2026-01-06T23:43Z [----] followers, [---] engagements


"$UAL -UBS raises United Airlines target to $145 from $142 Buy -Bank of America raises target to $130 from $120 Buy - $ULCC -Bank of America lowers Frontier Group target to $4 from $5 Downgrades to Underperform from Neutral - $ULTA -Barclays raises Ulta Beauty target to $680 from $647 Overweight - https://twitter.com/i/web/status/2008751695128678619 https://twitter.com/i/web/status/2008751695128678619"  
[X Link](https://x.com/MarcJacksonLA/status/2008751695128678619)  2026-01-07T04:04Z [----] followers, [---] engagements


"$CSGP CoStar Group Provides Full Year [----] and Medium-Term Outlook with Significant Adjusted EBITDA Expansion https://www.stocktitan.net/news/CSGP/co-star-group-provides-full-year-2026-and-medium-term-outlook-with-3kj9gbvkqs0g.html https://www.stocktitan.net/news/CSGP/co-star-group-provides-full-year-2026-and-medium-term-outlook-with-3kj9gbvkqs0g.html"  
[X Link](https://x.com/MarcJacksonLA/status/2008945302133444808)  2026-01-07T16:54Z [----] followers, [---] engagements


"$ACN -UBS maintains Accenture $320 target Buy - $AD -Citi raises Array Digital target to $63 from $37 Buy - $ADPT -Cowen lifts Adaptive Biotechnologies target to $20 from $19 Buy - $ALB -Baird raises Albemarle target to $210 from $113 Upgrades to Outperform from Neutral -"  
[X Link](https://x.com/MarcJacksonLA/status/2009030571679440927)  2026-01-07T22:33Z [----] followers, [---] engagements


"$ALK -Citi raises Alaska Airlines target to $69 from $61 Buy - $ALL -Evercore lowers Allstate target to $225 from $233 In-Line - $ALLO -UBS initiates Allogene Therapeutics coverage with a Buy rating highlighting [--] key upcoming catalysts -Sets $8 target https://www.investing.com/news/analyst-ratings/ubs-initiates-coverage-on-allogene-stock-with-buy-rating-8-price-target-93CH-4434009 https://www.investing.com/news/analyst-ratings/ubs-initiates-coverage-on-allogene-stock-with-buy-rating-8-price-target-93CH-4434009"  
[X Link](https://x.com/MarcJacksonLA/status/2009032619414180106)  2026-01-07T22:41Z [----] followers, [---] engagements


"$ASND -Cowen maintains Ascends Pharma $325 target Buy - $ASTS -Scotiabank downgrades AST Spacemobile to Sector Underperform from Sector Perform $45.60 target - $AVTR -Cowen lowers Avantor target to $12 from $14 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2009037676922720397)  2026-01-07T23:01Z [----] followers, [---] engagements


"$CHAG -Jefferies initiates Chagee coverage at Hold $14 target - $CHRW -Baird raises CH Robinson target to $175 from $162 Outperform - $CLX -Goldman lowers Clorox target to $94 from $110 Sell - $CMG -Barclays raises Chipotle Mexican Grill target to $44 from $38 = Weight -"  
[X Link](https://x.com/MarcJacksonLA/status/2009046854936469679)  2026-01-07T23:37Z [----] followers, [---] engagements


"$DRI -Barclays lowers Darden Restaurants target to $227 from $230 Overweight - $DRUG -Baird raises Bright Minds Biosciences target to $142 from $82 Outperform - $DSGN -Oppenheimer initiates Design Therapeutics coverage at Outperform $18 target - $EAT -Barclays raises Brinker target to $166 from $135 = Weight - https://twitter.com/i/web/status/2009109557231145356 https://twitter.com/i/web/status/2009109557231145356"  
[X Link](https://x.com/MarcJacksonLA/status/2009109557231145356)  2026-01-08T03:47Z [----] followers, [---] engagements


"$EVMN -Raymond James initiates Evommune coverage with a Strong Buy rating expecting [----] to be a 'catalyst rich year' for the company -Sets $40 target https://www.investing.com/news/analyst-ratings/raymond-james-initiates-evommune-stock-with-strong-buy-rating-40-target-93CH-4435931 https://www.investing.com/news/analyst-ratings/raymond-james-initiates-evommune-stock-with-strong-buy-rating-40-target-93CH-4435931"  
[X Link](https://x.com/MarcJacksonLA/status/2009110908187103252)  2026-01-08T03:52Z [----] followers, [---] engagements


"$FFAI Faraday Future Announces the FX Super One Roadmap for Mass Production Sales Delivery Service and Ramp-Up and Its Entry into Embodied AI Robotics along with Its Execution Plan for FF's Five-Year Business Plan https://www.stocktitan.net/news/FFAI/faraday-future-announces-the-fx-super-one-roadmap-for-mass-qcxz9o0ovnvm.html https://www.stocktitan.net/news/FFAI/faraday-future-announces-the-fx-super-one-roadmap-for-mass-qcxz9o0ovnvm.html"  
[X Link](https://x.com/MarcJacksonLA/status/2009115836490108996)  2026-01-08T04:11Z [----] followers, [---] engagements


"$IR -Wells Fargo raises Ingersoll Rand target to $92 from $87 Overweight - $ISRG -Barclays raises Intuitive Surgical target to $686 from $635 Overweight -BTIG lifts target to $616 from $589 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2009123551400611963)  2026-01-08T04:42Z [----] followers, [---] engagements


"$IVA UBS raises Inventiva target to $12 from $3 Upgrades to Buy from Neutral - $JACK -Barclays raises Jack in the Box target to $20 from $15 = Weight - $JBIO -HC Wainwright initiates Jade Biosciences coverage with a Buy rating -Sets $25 target https://www.investing.com/news/analyst-ratings/hc-wainwright-initiates-coverage-on-jade-biosciences-stock-with-buy-rating-93CH-4434865 https://www.investing.com/news/analyst-ratings/hc-wainwright-initiates-coverage-on-jade-biosciences-stock-with-buy-rating-93CH-4434865"  
[X Link](https://x.com/MarcJacksonLA/status/2009125930875408414)  2026-01-08T04:52Z [----] followers, [---] engagements


"$OGN $DSNKY Organon Enters into a Commercialization Agreement for Daiichi Sankyos Nilemdo in France Denmark Iceland Sweden Finland and Norway https://www.stocktitan.net/news/OGN/organon-enters-into-a-commercialization-agreement-for-daiichi-sankyo-iddich3iv3ia.html https://www.stocktitan.net/news/OGN/organon-enters-into-a-commercialization-agreement-for-daiichi-sankyo-iddich3iv3ia.html"  
[X Link](https://x.com/MarcJacksonLA/status/2009158364358692985)  2026-01-08T07:00Z [----] followers, [---] engagements


"$INKT MiNK Therapeutics and University of WisconsinMadison Announce Phase [--] Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease https://www.stocktitan.net/news/INKT/mi-nk-therapeutics-and-university-of-wisconsin-madison-announce-hfet62p2xxqm.html https://www.stocktitan.net/news/INKT/mi-nk-therapeutics-and-university-of-wisconsin-madison-announce-hfet62p2xxqm.html"  
[X Link](https://x.com/MarcJacksonLA/status/2009345857234280481)  2026-01-08T19:25Z [----] followers, [---] engagements


"$DK -Piper Sandler lowers Delek target to $40 from $47 Neutral - $DLTR -Barclays raises Dollar Tree target to $149 from $136 Overweight -Deutsche Bank resumes coverage at Hold $126 target - $DNA -Cowen lowers Gingko Bioworks target to $12 from $14 Buy -"  
[X Link](https://x.com/MarcJacksonLA/status/2009440054842937558)  2026-01-09T01:40Z [----] followers, [---] engagements


"$DPZ -Evercore lowers Domino's Pizza target to $490 from $510 Outperform - $DRI -Truist lowers Darden Restaurants target to $207 from $240 Downgrades to Hold from Buy - $DUOL -Wells Fargo lowers Duolingo target to $160 from $185 Underweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2009441751921246381)  2026-01-09T01:47Z [----] followers, [---] engagements


"$IQV -Truist raises IQVIA target to $290 from $265 Buy -UBS lifts target to $280 from $250 Buy - $IRON -Morgan Stanley raises Disc Medicine target to $120 from $115 Overweight - $JACK -Truist raises Jack in the Box target to $18 from $16 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2009470066035933597)  2026-01-09T03:39Z [----] followers, [---] engagements


"$PHR -Wells Fargo initiates Phreesia coverage at Overweight $30 target -Truist lowers target to $24 from $29 Buy - $PSX -Piper Sandler lowers Phillips66 target to $155 from $171 Neutral - $PTCT -Morgan Stanley raises PTC Therapeutics target to $90 from $78 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2009494281057390912)  2026-01-09T05:15Z [----] followers, [---] engagements


"$STLA -Piper Sandler raises Stellantis target to $15 from $9 Upgrades to Overweight from Neutral - $STZ -UBS reiterates Constellation Brands $170 target Buy -Wells Fargo raises target to $165 from $160 Overweight - $TECX -Truist lowers Tectonic Therapeutics target to $60 from $64 Buy - https://twitter.com/i/web/status/2009498971111117182 https://twitter.com/i/web/status/2009498971111117182"  
[X Link](https://x.com/MarcJacksonLA/status/2009498971111117182)  2026-01-09T05:34Z [----] followers, [---] engagements


"$TGT -Deutsche Bank resumes Target coverage at Hold $108 target - $TJX -UBS raises TJX Companies target to $193 from $181 Buy -Deutsche Bank sets $184 target Buy - $TNYA -Morgan Stanley lowers Tenaya Therapeutics target to $2 from $5 Overweight -"  
[X Link](https://x.com/MarcJacksonLA/status/2009499541603844137)  2026-01-09T05:36Z [----] followers, [---] engagements


"$TOST -Wolfe Research downgrades Toast to Peer Perform from Outperform - $TPR -UBS raises Tapestry target to $123 from $105 Neutral - $TRIP -Cantor Fitzgerald lowers TripAdvisor target to $14 from $15 Underweight - $TSCO -Gordon Haskett lowers Tractor Supply target to $50 from $57 Downgrades to Hold from Accumulate - https://twitter.com/i/web/status/2009500268581232979 https://twitter.com/i/web/status/2009500268581232979"  
[X Link](https://x.com/MarcJacksonLA/status/2009500268581232979)  2026-01-09T05:39Z [----] followers, [---] engagements


"$WAB -Wolfe Research upgrades Wabtec to Outperform from Peer Perform $245 target - $WEN -Truist lowers Wendy's target to $11 from $12 Buy -Evercore lowers target to $9 from $11 In-Line -"  
[X Link](https://x.com/MarcJacksonLA/status/2009504237903073652)  2026-01-09T05:55Z [----] followers, [---] engagements


"$ZBH -BTIG reiterates Zimmer Biomet $112 target Buy - $ZG -Cantor Fitzgerald lowers Zillow Group target to $68 from $74 Neutral --"  
[X Link](https://x.com/MarcJacksonLA/status/2009505698699452428)  2026-01-09T06:01Z [----] followers, [---] engagements


"$ADBE -BMO lowers Adobe target to $375 from $400 Downgrades to Market Perform fro Outperform - $ADSK -Rothschild Redburn initiates Autodesk coverage at Buy $375 target - $AEHR -Craig Hallum lowers Aehr Test Systems target to $21 from $24 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2009740355172733301)  2026-01-09T21:33Z [----] followers, [---] engagements


"$CRL -Baird raises Charles River Laboratories target to $224 from $199 Outperform -Mizuho lifts target to $215 from $200 Neutral - $CRWD -Berenberg Bank upgrades CrowdStrike to Buy from Hold - $CTSH -Cowen raises Cognizant target to $84 from $78 Hold -"  
[X Link](https://x.com/MarcJacksonLA/status/2010075753111847159)  2026-01-10T19:46Z [----] followers, [---] engagements


"$DOCS -Goldman raises Doximity target to $62 from $49 Upgrades to Neutral from Sell - $DXCM -Bernstein lifts DexCom target to $86 from $84 Outperform - $EAT -Citi raises Brinker target to $187 from $176 Buy -Mizuho raises target to $175 from $155 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2010076999155667453)  2026-01-10T19:51Z [----] followers, [---] engagements


"$LIF -Citi lowers Life360 target to $79.50 from $96.80 Buy - $LINE -Scotiabank lifts Lineage target to $39 from $37 Sector Perform - $LITE -Mizuho raises Lumentum target to $455 from $325 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2010114248886874339)  2026-01-10T22:19Z [----] followers, [---] engagements


"$PZZA -Mizuho lowers Papa John's target to $40 from $44 Neutral - $QCOM -Mizuho lowers Qualcomm target to $175 from $200 Downgrades to Neutral from Outperform - $QRVO -Mizuho lowers Qorvo target to $85 from $93 Neutral - $QXO -RBC lowers QXO target to $30 from $33 Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/2010147138336968984)  2026-01-11T00:29Z [----] followers, [---] engagements


"$RACE -UBS lowers Ferrari target to $555 from $563 Buy -Bernstein maintains $395 target Outperform - $RANI -HC Wainwright reiterates Rani therapeutics $11 target Buy - $RAPT -Piper Sandler initiates Rapt Therapeutics coverage at Overweight $95 target -"  
[X Link](https://x.com/MarcJacksonLA/status/2010147699476312293)  2026-01-11T00:32Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@MarcJacksonLA Avatar @MarcJacksonLA stock setter

Several companies across various sectors have recent target changes from analysts. Notable changes include upgrades and downgrades for companies such as American Tower, EOG Resources, and Aptiv. Additionally, some companies like Alaska Airlines and UnitedHealth have made significant announcements that may impact their stock performance. Analysts are also showing interest in companies like Neurocrine Biosciences and Faraday Future.

Engagements: [------] #

Engagements Line Chart

  • [--] Week [-------] +13%
  • [--] Month [-------] +84%
  • [--] Months [---------] -16%
  • [--] Year [---------] +21%

Mentions: [---] #

Mentions Line Chart

  • [--] Week [-----] +4.20%
  • [--] Month [-----] +9.40%
  • [--] Months [------] +1.90%
  • [--] Year [------] +28%

Followers: [-----] #

Followers Line Chart

  • [--] Week [-----] +0.20%
  • [--] Month [-----] +0.89%
  • [--] Months [-----] +6.50%
  • [--] Year [-----] +27%

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 91.34% cryptocurrencies #5225 technology brands 13.38% financial services #869 finance 7.27% countries 6.16% currencies 2.84% automotive brands 2.45% exchanges 1.01% fashion brands 0.67%

Social topic influence target #600, $barcl #45, morgan stanley #27, bank of #358, bank of america #67, morgan #93, health 2.6%, $19 #34, $21 #27, bank #289

Top accounts mentioned or mentioned by @medtechdive @statnews @biopharmadive @barchart @streetinsider @fwpharma @businessinsider @bs @techzine @ft @bitcoinmagazine @yachmod @mattkiu @imcryptopus @darrenc777 @itsa68891 @james_wilsfile @mitchellreed09 @kristinadavis90 @cameron_br_pres

Top assets mentioned Morgan Stanley (MS) Bank of America (BAC) Born in [--] (19) 2131KOBUSHIDE (21) HSBC Holdings PLC (HSBC) The 99% Community (99) The Official [--] Coin (93) Johnson & Johnson (JNJ) The Official [--] coin (76) Novartis AG (NVS) 69Coin (69) Flutter Entertainment plc (FLUT) Gilead Sciences, Inc. (GILD) AstraZeneca PLC (AZN) Atlassian Corporation PLC (TEAM) Eli Lilly and Company (LLY) Now Coin (NOW) Basilisk (BSX) PayPal Holdings Inc (PYPL) Legend Biotech Corp (LEGN) GSK plc (GSK) DuPont de Nemours Inc (DD) The Official [--] Coin (89) (89) monday.com Ltd. (MNDY) CatCoin (CAT) Teradyne, Inc. (TER) Synthetify (SNY) Novo-Nordisk (NVO) Merck & Co., Inc. (MRK) Walmart, Inc. (WMT) Hims & Hers Health, Inc. (HIMS) Tapestry, Inc. (TPR) Amgen, Inc. (AMGN) Popular Inc (BPOP) Biogen Inc (BIIB) Inspect (INSP) Rapids (RPD) Doximity, Inc. (DOCS) Applied Materials, Inc. (AMAT) Devon Energy Corp (DVN) Baker Hughes Co (BKR) Pfizer, Inc. (PFE) Pinterest, Inc. (PINS) Evolent Health, Inc Class A Common Stock (EVH) AbbVie Inc (ABBV) Copiosa Coin (COP2) Waystar Holding Corp (WAY) Lumentum Holdings Inc. Common Stock (LITE) AME Chain (AME) Emerson Electric Co. (EMR) Western Digital Corp (WDC) Trade Desk, Inc. (TTD) Erasca, Inc. (ERAS) Intuit Inc. (INTU) Datadog Inc (DDOG) Analog Devices, Inc. (ADI) Orochi Network (ON) Regal Rexnord, Corp. (RRX) Coca-Cola Co (KO) Klarna Group plc (KLAR) Boston Scientific Corporation (BSX) Zimmer Biomet Holdings Inc (ZBH) Evommune, Inc. (EVMN) Praxis Precision Medicines, Inc. (PRAX) Marriott International Inc (MAR) MKS Instruments Inc (MKSI) Royalty Pharma plc (RPRX) Duolingo, Inc. (DUOL) Zillow Group, Inc. (ZG) Adobe, Inc. (ADBE) Lam Research Corporation (LRCX) Paylocity Holding, Corp. (PCTY) Bristol-Myers Squibb Co (BMY) Alphabet Inc Class A (GOOGL) Roper Technologies Inc (ROP) ArcelorMittal (MT) Moon Tropica (CAH) Snap, Inc. (SNAP)

Top Social Posts

Top posts by engagements in the last [--] hours

"$BDTX -Piper Sandler lowers Black Diamond Therapeutics target to $8 from $9 Overweight - $BGS -Cowen lifts B&G Foods target to $3.50 from $3 Sell -"
X Link 2026-01-16T20:34Z [----] followers, [---] engagements

"$CROX -KeyBanc downgrades Crocs to Sector Weight from Overweight - $CTRE -Citizens JMP initiates CareTrust REIT coverage at Market Outperform $44 target - $CTSH -Berenberg Bank initiates Cognizant coverage at Buy $107 target -Citi raises target to $86 from $75 Buy -"
X Link 2026-01-22T19:10Z [----] followers, [---] engagements

"$ADP -Cantor Fitzgerald initiates Automatic Data Processing coverage at Overweight $306 target - $AESI -Stephens lowers Atlas Energy target to $16 from $20 Overweight - $AEYE -HC Wainwright lowers Audioeye target to $18 from $22 Buy - $AFRM -Needham upgrades Affirm to Buy from Hold $100 target - https://twitter.com/i/web/status/2016301042418516344 https://twitter.com/i/web/status/2016301042418516344"
X Link 2026-01-28T00:03Z [----] followers, [---] engagements

"$ATKR -Roth raises Atkore target to $77 from $71 Buy -Citi raises target to $74 from $64 Neutral -RBC raises target to $71 from $64 Sector Perform - $AVNW -Roth lowers Aviat Networks target to $38 from $41 Buy -B. Riley raises target to $36 from $35 Buy - $AXP -UBS lowers American Express target to $395 from $414 Neutral - https://twitter.com/i/web/status/2019112912640704969 https://twitter.com/i/web/status/2019112912640704969"
X Link 2026-02-04T18:16Z [----] followers, [---] engagements

"$CDP -Evercore raises COPT Defense target to $36 from $34 Outperform - $CI -RBC lowers Cigna target to $333 from $344 Outperform -Barclays lowers target to $303 from $305 Overweight -Leerink raises target to $297 from $270 Market Perform -"
X Link 2026-02-07T00:24Z [----] followers, [---] engagements

"$BSY -Oppenheimer lowers Bentley Systems target to $53 from $65 Outperform - $BTU -Jefferies raises Peabody Energy target to $44 from $42 Buy - $CAKE -Morgan Stanley raises Cheesecake Factory target to $50 from $49 Underweight - $CAMT -Needham raises Camtek target to $160 from $135 Buy - https://twitter.com/i/web/status/2013718414473470346 https://twitter.com/i/web/status/2013718414473470346"
X Link 2026-01-20T21:00Z [----] followers, [---] engagements

"$AAP -Northcoast Research upgrades Advance Auto Parts to Buy from Neutral $55 target - $ACDC -Morgan Stanley raises ProFrac target to $4 from $3.50 Underweight - $ACET -HC Wainwright raises Adicet Bio target to $50 from $9 on clinical progress Reiterates Buy rating https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-adicet-bio-stock-price-target-to-50-on-clinical-progress-93CH-4457504 https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-adicet-bio-stock-price-target-to-50-on-clinical-progress-93CH-4457504"
X Link 2026-01-21T17:20Z [----] followers, [---] engagements

"$BIIB -Bernstein lowers Biogen target to $191 from $197 Market Perform - $BLK -CICC raises BlackRock target to $1250 from $1000 - $BPOP -Bank of America upgrades Popular to Buy from Neutral $156 target - $BSX -Barclays lowers Boston Scientific target to $124 from $136 Overweight"
X Link 2026-02-03T18:40Z [----] followers, [---] engagements

"$BSX -UBS lowers Boston Scientific target to $120 from $140 Buy -Morgan Stanley lowers target to $118 from $130 Overweight -Mizuho lowers target to $115 from $140 Outperform -RBC lowers target to $115 from $130 Outperform -Canaccord lowers target to $112 from $131 Buy -Citi lowers target to $102 from $130 Buy -Baird lowers target to $101 from $118 Outperform -Goldman lowers target to $99 from $102 Buy -Needham lowers target to $97 from $121 Buy -Evercore lowers target to $96 from $112 Outperform -Truist lowers target to $95 from $120 Buy -Wells Fargo lowers target to $94 from $125 Overweight"
X Link 2026-02-05T18:43Z [----] followers, [---] engagements

"$BSX Boston Scientific Stock Price Steadies After Historic Plunge as Investors Zero In on Heart Rhythm Outlook https://ts2.tech/en/boston-scientific-stock-price-steadies-after-historic-plunge-as-investors-zero-in-on-heart-rhythm-outlook/ https://ts2.tech/en/boston-scientific-stock-price-steadies-after-historic-plunge-as-investors-zero-in-on-heart-rhythm-outlook/"
X Link 2026-02-06T17:16Z [----] followers, [---] engagements

"$CPAY -Mizuho raises Corday target to $340 from $320 Neutral - $CPT -Stifel lowers Camden Property Trust target to $118.50 from $120.50 Buy - $CRSR -Wedbush lowers Corsair Gaming target to $7 fro $9 Outperform -B. Riley lowers target to $6 from $7.50 Neutral -"
X Link 2026-02-07T01:05Z [----] followers, [---] engagements

"$BSX $MDT $ABT $JNJ Boston Scientific Farapulse PFA Outperforms Thermal Ablation in Study https://www.massdevice.com/boston-scientific-farapulse-outperforms-thermal-study/ https://www.massdevice.com/boston-scientific-farapulse-outperforms-thermal-study/"
X Link 2026-02-10T01:16Z [----] followers, [---] engagements

"$AMD -Evercore raises Advanced Micro Devices target to $328 from $283 Outperform -Benchmark maintains $325 target Buy -UBS lowers target to $310 from $330 Buy -KeyBanc raises target to $300 from $270 Overweight -Rosenblatt Roth maintain $300 target Buy -Wedbush maintains $290 target Outperform -Truist raises target to $283 from $277 Buy -Morgan Stanley lowers target to $255 from $260 = Weight -Bernstein raises target to $235 from $225 Market Perform https://twitter.com/i/web/status/2019109911221924242 https://twitter.com/i/web/status/2019109911221924242"
X Link 2026-02-04T18:04Z [----] followers, [---] engagements

"$PYPL PayPal's former president slams the company says it's lost its 'mojo' and 'ability to compete' via @businessinsider https://www.businessinsider.com/paypal-former-president-david-marcus-lost-mojo-criticism-2026-2utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter https://www.businessinsider.com/paypal-former-president-david-marcus-lost-mojo-criticism-2026-2utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter"
X Link 2026-02-05T01:01Z [----] followers, [---] engagements

"$APP -UBS lowers AppLovin target to $686 from $840 Buy - $ARWR -HC Wainwright reiterates Arrowhead Pharmaceuticals $100 target Buy - $AXP -Evercore lowers American Express target to $393 from $400 In-Line - $BCO -Truist raises Brink's target to $163 from $138 Buy -"
X Link 2026-02-10T23:45Z [----] followers, [---] engagements

"$SPRY - ARS Pharmaceuticals Announces FDA Approval of neffy [--] mg (epinephrine nasal spray) for Type I Allergic Reactions Including Anaphylaxis in Pediatric Patients Weighing [--] to [--] Kilograms - https://www.globenewswire.com/news-release/2025/03/05/3037769/0/en/ARS-Pharmaceuticals-Announces-FDA-Approval-of-neffy-1-mg-epinephrine-nasal-spray-for-Type-I-Allergic-Reactions-Including-Anaphylaxis-in-Pediatric-Patients-Weighing-15-to-30-Kilogra.html"
X Link 2025-03-05T22:30Z [----] followers, [---] engagements

"$ABCL $LLY $ABBV $NVS -AbCellera Biologics: Fueling Growth Through Strategic Partnerships R&D - https://www.ainvest.com/news/abcellera-biologics-fueling-growth-strategic-partnerships-reinvention-2506/ https://www.ainvest.com/news/abcellera-biologics-fueling-growth-strategic-partnerships-reinvention-2506/"
X Link 2025-07-01T23:43Z [----] followers, [----] engagements

"$IDXX -Morgan Stanley raises IDEXX Laboratories target to $765 from $722 Overweight - $INKT -HC Wainwright upgrades MiNK Therapeutics to Buy from Neutral $35 target - $INSP -Leekrink lowers Inspire Medical Systems target to $97 from $116 Market Perform -"
X Link 2025-08-15T23:02Z [----] followers, [---] engagements

"$USB -Truist raises US Bancorp target to $51 from $49 Hold - $VCEL BTIG downgrades Vericel to Neutral from Buy - $VTEX -Jefferies upgrades VTEX to Buy from Hold Lowers target to $6.50 from $7.30 - $WCN -Citi lowers Waste Connections target to $199 from $204 Neutral -"
X Link 2025-09-17T20:30Z [----] followers, [---] engagements

"$IFF -Berenberg Bank lowers International Flavors & Fragrances target to $78.30 from $78.80 Hold - $IMUX -Chardan Capital initiates Immunic coverage Buy $13 target - $INTC -Deutsche Bank raises Intel target to $30 from $23 Hold -"
X Link 2025-09-29T18:55Z [----] followers, [---] engagements

"$ODFL -UBS raises Old Dominion Freight target to $164 from $155 Neutral - $OEC -Mizuho lowers Orion target to $7 from $9 Underperform - $OLN -Mizuho raises Olin target to $26 from $23 Neutral - $OSIS -Oppenheimer raises OSI Systems target to $280 from $270 Outperform -"
X Link 2025-10-04T23:59Z [----] followers, [---] engagements

"$IMMP Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress [----] https://www.stocktitan.net/news/IMMP/primary-endpoint-met-in-eftisarc-neo-phase-ii-evaluating-neoadjuvant-oz0c0akcfofz.html https://www.stocktitan.net/news/IMMP/primary-endpoint-met-in-eftisarc-neo-phase-ii-evaluating-neoadjuvant-oz0c0akcfofz.html"
X Link 2025-10-20T14:16Z [----] followers, [---] engagements

"$TYL -Baird lowers Tyler Technologies target to $660 from $720 Outperform -Evercore to $575 from $595 In-Line -DA Davidson to $540 from $560 Neutral - $U -BTIG upgrades Unity to Neutral from Sell - $UPBD -Cowen lowers Unbound target to $31 from $36 Buy -BTIG to $28 from $40 Buy - https://twitter.com/i/web/status/1985183681238225268 https://twitter.com/i/web/status/1985183681238225268"
X Link 2025-11-03T03:14Z [----] followers, [---] engagements

"$COLL -Truist raises Collegium Pharmaceuticals target to $48 from $45 Buy -HC Wainwright to $46 from $4 Buy - $COP -JPMorgan lowers ConocoPhillips target to $112 from $115 Overweight - $COR -UBS raises Cencora target to $415 from $380 Buy -"
X Link 2025-11-08T18:21Z [----] followers, [---] engagements

"$DCBO -Needham lowers Docebo target to $38 from $42 Buy - $DD -Wells Fargo lowers Dupont target to $50 from $100 Overweight -Citi raises target to $47 from $38 Buy -"
X Link 2025-11-08T18:36Z [----] followers, [---] engagements

"$GOOS -Evercore raises Canada Goose target to $12 from $11 In-Line -UBS lifts target to $12 from $11 Neutral - $GWW -Barclays raises WW Grainger target to $975 from $963 Underweight - $H -Barclays raises Hyatt Hotels target to $161 fro $156 =nWeight -"
X Link 2025-11-08T22:56Z [----] followers, [---] engagements

"$PRTA -HC Wainwright raises Prothena target to $30from $20 Buy -RBC lifts target to $11 from $10 Sector Perform - $PRVA -Citizens JMP raises Privia Health target to $31 from $30 Market Outperform -Evercore lifts target to $30 from $28 Outperform -"
X Link 2025-11-09T23:05Z [----] followers, [---] engagements

"$QGEN $MYGN QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP [----] - QIAsymphony Connect the next generation of automated nucleic acid purification platform to be shown at AMP [----] as early access phase begins ahead of full release in mid-2026 - QIAGEN showcases Sample to Insight workflows for comprehensive genomic profiling (CGP) based on Element Biosciences Trinity technology - Partnership with Myriad Genetics to highlight development of a homologous recombination deficiency (HRD) assay for use in cancer profiling"
X Link 2025-11-10T07:15Z [----] followers, [---] engagements

"$TMCI -Truist lowers Treace Medical target to $4 from $7 Hold - $TNDM -Barclays raises Tandem Diabetes Care target to $55 from $50 Overweight -Morgan Stanley to $17 from $13 = Weight -Truist to $17 from $16 Hold - $TNYA -Chardan Capital maintains Tenaya Therapeutics $9 target Buy - https://twitter.com/i/web/status/1988068457154519383 https://twitter.com/i/web/status/1988068457154519383"
X Link 2025-11-11T02:17Z [----] followers, [---] engagements

"$ZBH -Canaccord lowers Zimmer Biomet target to $93 from $101 Hold - $ZD -UBS lowers Ziff Davis target to $38 from $40 Neutral -Citi to $35 from $42 Neutral -Barclays to $34 from $40 = Weight -"
X Link 2025-11-11T02:39Z [----] followers, [---] engagements

"$MGTX -Chardan Capital reiterates MeiraGTX $35 target Buy -Piper Sandler raises target to $30 from $28 Overweight - $MIDD -Barclays lowers Middleby target to $168 from $180 Overweight - $MLM -JPMorgan raises Martin Marietta target to $700 from $670 Overweight -Stifel to $681 from $637 Buy - https://twitter.com/i/web/status/1988309274226029020 https://twitter.com/i/web/status/1988309274226029020"
X Link 2025-11-11T18:14Z [----] followers, [---] engagements

"$VSAT -JPMorgan raises Viasat target to $50 from $23 Upgrades to Overweight from Neutral -Needham raises target to $45 from $25 Buy - $VYGR -Wedbush maintains Voyager Therapeutics $8 target Outperform - $WAY -Needham initiates Waystar coverage at Buy $46 target -"
X Link 2025-11-11T22:06Z [----] followers, [---] engagements

"$PVLA -Canaccord raises Palvella Therapeutics target to $148 from $90 Buy -Chardan Capital maintains $110 target Buy - $PYPD -Roth lowers PolyPid target to $9 from $10 Buy - $RAMP -Morgan Stanley raises Live Ramp target to $33 from $30 = Weight -"
X Link 2025-11-13T23:09Z [----] followers, [---] engagements

"$AVDL Avadel Receives Unsolicited Proposal from Lundbeck Avadel received an unsolicited proposal from H. Lundbeck A/S to acquire Avadel for up to $23.00 per share$21.00 cash at closing plus a non-transferable CVR worth up to $2.00 tied to U.S. net sales milestones for LUMRYZ and valiloxybate by [----] and [----]. Avadel noted the Lundbeck Proposal is subject to shareholder and regulatory approvals and closing conditions. The Avadel Board determined in good faith the Lundbeck Proposal would reasonably be expected to result in a Company Superior Proposal under its agreement with Alkermes permitting"
X Link 2025-11-14T15:33Z [----] followers, [---] engagements

"$HURN -Truist raises Huron target to $240 from $180 Buy - $HWM -Bank of America raises Howmet Aerospace target to $250 from $215 Buy - $IMUX -HC Wainwright lowers Immunic target to $8 from $10 Buy - $INO -Piper Sandler raises Inovio Pharmaceuticals target to $6 from $5 Overweight"
X Link 2025-11-15T20:05Z [----] followers, [---] engagements

"$EXPO -William Blair upgrades Exponent to Outperform from Market Perform on strong Q3 results https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868 https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868"
X Link 2025-11-17T19:17Z [----] followers, [---] engagements

"$NKE -JPMorgan lowers NIKE target to $86 from $100 Overweight - $NMRA -Stifel raises Neumora Therapeutics target to $3 from $2 Hold - $NP -Morgan Stanley raises Neptune Insurance target to $27 from $26 = Weight - $NRXP -D. Boral maintains NRX Pharmaceuticals $34 target Buy -"
X Link 2025-11-17T22:30Z [----] followers, [---] engagements

"$RCKT -Barclays lowers Rocket Pharmaceuticals target to $8 from $10 = Weight -JPMorgan downgrades to Underweight from Neutal - $RCL -Wells Fargo initiates Royal Caribbean coverage at Overweight $320 target - $REG -Barclays lowers Regency Centers target to $82 from $83 Upgrades to Overweight from = Weight -Truist lowers target to $77 from $81 Buy - https://twitter.com/i/web/status/1990964078999974003 https://twitter.com/i/web/status/1990964078999974003"
X Link 2025-11-19T02:03Z [----] followers, [---] engagements

"$TEAM -Bernstein raises Atlassian target to $304 from $290 Outperform - $TELA -Canaccord lowers TELA Bio target to $4 from $7 Buy - $TERN -BMO raises Terns Pharmaceuticals target to $30 from $22 Outperform - $TKO -BTIG reiterates TKO Group $235 target Buy -"
X Link 2025-11-19T02:27Z [----] followers, [---] engagements

"$AN -Evercore raises AutoNation target to $300 from $240 Outperform - $ANAB -HC Wainwright lowers AnaptysBio target to $51 from $52 Buy -Wedbush maintains $50 target Outperform - $APA -Raymond James reiterates APA $31 target Outperform -"
X Link 2025-11-24T17:37Z [----] followers, [---] engagements

"$LSPD Lightspeed Commerce Unveils Tempo a New Pacing Intelligence for Restaurants Lightspeed's Tempo is a pacing intelligence built into Lightspeed Restaurant that uses real-time dining flow data to guide servers and managers through service moments. Tempo aims to make pacing measurable and coachable to improve guest experience increase table turns and boost staff performance. The product is available to Lightspeed Restaurant customers and will expand connectivity with Lightspeed systems such as Kitchen Display and Pulse."
X Link 2025-11-24T17:47Z [----] followers, [---] engagements

"$BNTC -HC Wainwright lowers Benitec Biopharma target to $32 from $35 Buy - $BRBR -Mizuho lowers BellRing Brands target to $40 from $45 Outperform - $BWA -Evercore raises BorgWarner target to $53 from $50 Outperform - $C -UBS maintains Citigroup $108 target Neutral -"
X Link 2025-11-24T22:37Z [----] followers, [---] engagements

"$IMA -Wedbush assumes Imagene Bio coverage at Underperform $2 target - $IMAX -Goldman raises IMAX target to $34 from $22 Upgrades to Neutral from Sell - $INSP -Wolfe Research upgrades Inspire Medical Systems to Outperform from Peer Perform $180 target - $INVH -Barclays lowers Invitation Homes target to $34 from $37 Overweight - https://twitter.com/i/web/status/1993430827204780455 https://twitter.com/i/web/status/1993430827204780455"
X Link 2025-11-25T21:25Z [----] followers, [---] engagements

"$WMG -Goldman lifts Warner Music Group target to $32 from $31 Neutral - $WT -Goldman lowers WisdomTree target to $13.25 from $14.75 Neutral - $WWD -UBS raises Woodward target to $329 from $303 Buy -Truist lifts target to $305 from $294 Buy -"
X Link 2025-11-26T01:08Z [----] followers, [---] engagements

"$BLLN -Analysts initiate Billiontoone coverage -BTIG Buy $160 target -JPMorgan Piper Sandler Overweight $150 target -Stifel Buy $145 target -William Blair Outperform -Jefferies Hold $117 target -Wells Fargo = Weight $110 target -"
X Link 2025-12-01T17:14Z [----] followers, [---] engagements

"$CDNS -Oppenheimer lifts Cadence Design target to $275 from $225 Upgrades to Market Perform from Underperform - $CDRO -Benchmark maintains Codere Online at Hold - $CEVA -Loop Capital starts CEVA coverage at Buy $28 target - $CFG -Cowen maintains Citizens Financial $75 target Buy"
X Link 2025-12-01T18:05Z [----] followers, [---] engagements

"$EVMN -Analysts initiate Evommune coverage -Leerink Outperform $42 target -Evercore Outperform $40 target -Morgan Stanley Overweight $36 target -Cantor Fitzgerald Overweight -William Blair Outperform - $FAT -Noble Financial downgrades FAT Brands to Market Perform from Outperform - https://twitter.com/i/web/status/1995561202781724913 https://twitter.com/i/web/status/1995561202781724913"
X Link 2025-12-01T18:30Z [----] followers, [---] engagements

"$PK -Wells Fargo lowers Park Hotels target to $11 from $12 = Weight - $PMN -HC Wainwright raises Promis Neurosciences target to $18 from $4 Buy - $POST -Mizuho lowers Post target to $120 from $122 Outperform - $PRAX -Needham reiterates Praxis Precision Medicines $250 target Buy -"
X Link 2025-12-01T22:51Z [----] followers, [---] engagements

"$PRTA -Citizens JMP raises Prothena target to $19 from $11 Market Outperform - $PSA -Evercore lowers Public Storage target to $309 from $315 In-Line - $PSIX -Jefferies intiates Power Solutions coverage at Buy $110.51 target https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925 https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925"
X Link 2025-12-01T22:55Z [----] followers, [---] engagements

"$PTCT -RBC raises PTC Therapeutics target to $91 from $82 Downgrades to Sector Perform from Outperform - $RBRK -Guggenheim reiterates Rubrik $108 target Buy - $RCI -Cowen maintains Rogers Communications $64 target Buy - $RCL -Wells Fargo lowers Royal Caribbean target to $316 from $320 Overweight - https://twitter.com/i/web/status/1995628754924962234 https://twitter.com/i/web/status/1995628754924962234"
X Link 2025-12-01T22:59Z [----] followers, [---] engagements

"$MH -BTIG raises McGraw Hill target to $22 from $19 Buy - $MRK -Goldman raises Merck & Co. target to $120 from $92 Buy - $MTD -Morgan Stanley initiates Mettler-Toledo coverage at = Weight $1550 target - $MU -Wolfe Research raises Micron target to $300 from $200 Outperform -"
X Link 2025-12-02T23:01Z [----] followers, [---] engagements

"$BFRI Biofrontera Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz-PDT - sNDA for treatment of sBCC with Ameluz-PDT submitted to U.S. Food and Drug Administration (FDA) on November [--] [----] - First Phase [--] PDT study in patients with sBCC in the United States submitted to FDA - Primary and key secondary endpoints met with high statistical significance (p 0.0001) - Favorable recurrence outcomes at one-year follow-up - BCC is the most common skin cancer in the US with more than [--] million cases diagnosed annually"
X Link 2025-12-02T23:09Z [----] followers, [---] engagements

"$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html"
X Link 2025-12-03T15:07Z [----] followers, [---] engagements

"$ADCT ADC slides on latest Zynlonta update - Deteriorating efficacy and a treatment-related death with Zynlonta plus Columvi spook investors https://www.oncologypipeline.com/apexonco/adc-slides-latest-zynlonta-update https://www.oncologypipeline.com/apexonco/adc-slides-latest-zynlonta-update"
X Link 2025-12-03T17:07Z [----] followers, [---] engagements

"$NBP NovaBridge Announces Presentation of Ragistomig Expanded Phase [--] Data at ESMO-IO - Ragistomig is a 4-1BB X PD-L1 bispecific antibody designed to treat patients who are relapsed or refractory to checkpoint inhibitors a multi-billion dollar drug class hampered by widespread resistance - Phase [--] ragistomig study achieved its objective as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders with an improved safety profile - The interim results including immunological data on CD8+ cell proliferation and memory T-cell activation are expected to be"
X Link 2025-12-04T05:03Z [----] followers, [---] engagements

"$DTCX $TZUP Thumzup Media Corporation Plans Name Change to Datacentrex Inc. https://www.stocktitan.net/news/DTCX/thumzup-media-corporation-plans-name-change-to-datacentrex-a4a4ftap55a5.html https://www.stocktitan.net/news/DTCX/thumzup-media-corporation-plans-name-change-to-datacentrex-a4a4ftap55a5.html"
X Link 2025-12-04T15:17Z [----] followers, [---] engagements

"$MAR -Truist raises Marriott International target to $283 from $278 Hold - $MASI -BTIG raises Masimo target to $200 from $198 Buy - $MAZE -Wells Fargo initiates Maze Therapeutics coverage at Overweight $55 target https://www.investing.com/news/analyst-ratings/maze-therapeutics-stock-rating-initiated-at-overweight-by-wells-fargo-93CH-4390481 https://www.investing.com/news/analyst-ratings/maze-therapeutics-stock-rating-initiated-at-overweight-by-wells-fargo-93CH-4390481"
X Link 2025-12-05T03:48Z [----] followers, [---] engagements

"$REGN -Canaccord raises Regeneron target to $1057 from $850 Buy -BMO raises target to $850 from $725 Outperform - $REXR -Mizuho lifts Rexford Industrial target to $41 from $40 Neutral - $RHP -Truist raises Ryman Hospitality target to $121 from $120 Buy -"
X Link 2025-12-05T04:58Z [----] followers, [---] engagements

"$ORIC $AVBP $BDTX $BAYRY ESMO Asia [----] Orics first-line gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble"
X Link 2025-12-05T14:36Z [----] followers, [---] engagements

"$AGX -Lake Street lifts Argan target to $325 from $260 Downgrades to Hold from Buy - $AIG -Barclays lowers American International Group target to $88 from $95 Downgrades to = Weight from Overweight - $AJG -Wells Fargo lowers Arthur J. Gallagher target to $344 from $362 Overweight"
X Link 2025-12-05T17:10Z [----] followers, [---] engagements

"$RHI -BNP Paribas downgrades Robert Half to Underperform from Neutral $22 target - $RNR -BMO raises RenaissanceRe target to $303 from $294 Outperform - $ROL -Barclays raises Rollins target to $72 from $60 Upgrades to Overweight from = Weight -"
X Link 2025-12-06T23:22Z [----] followers, [---] engagements

"$VERA -Cowen raises Vera Therapeutics target to $73 from $60 Buy - $VITL -Needham initiates Vital Farms coverage with a Buy rating $45 target - $VRTX -Morgan Stanley raises Vertex Pharmaceuticals target to $564 from $516 Overweight -"
X Link 2025-12-07T00:43Z [----] followers, [---] engagements

"$EVO $SDZNY Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz - Agreement includes approximately US $350m in cash for Just - Evotec Biologics manufacturing site in Toulouse and upfront technology license fees to Evotec's continuous manufacturing platform - Evotec also eligible for license fees and development revenues including success-based milestones adding up to more than US $300m over the coming yearsreplacing existing contractual commitments - Transaction covering royalties on a portfolio ofup to ten biosimilars in technical and early development targeting more than"
X Link 2025-12-08T06:45Z [----] followers, [---] engagements

"$APTV -Morgan Stanley raises Aptiv target to $84 from $60 Upgrades to = Weight from Underweight - $AR -JPMorgan lowers Antero Resources target to $39 from $44 Downgrades to Neutral from Overweight - $ARGX -JPMorgan raises argenx target to $1100 from $925 Overweight -"
X Link 2025-12-08T17:10Z [----] followers, [---] engagements

"$FVR -Morgan Stanley raises FrontView REIT target to $17 from $15 = Weight - $GEN -Benchmark reiterates Genius Sports $16 target Buy - $GLTO -Guggenheim raises Alecto target to $36 from $32 Buy -"
X Link 2025-12-08T21:41Z [----] followers, [---] engagements

"$LYEL -HC Wainwright raises Lyell Immunopharma target to $45 from $20 Upgrades to Buy from Neutral - $LYFT -Wells Fargo lifts Lyft target to $26 from $20 = Weight - $MAIN -RBC trims Main Street Capital target to $66 from $67 Outperform -"
X Link 2025-12-09T22:52Z [----] followers, [---] engagements

"$TEVA -Barclays initiates Teva Pharmaceutical coverage at Overweight $35 target -Bank of America raises target to $32 from $29 Buy - $TFX -Needham maintains Teleflex Hold rating - $TGT -Evercore lowers Target target to $95 fro $100 In-Line -"
X Link 2025-12-10T00:57Z [----] followers, [---] engagements

"$CNM -Baird raises Core & Main target to $64 from $62 Outperform -JPMorgan to $59 from $58 Overweight -Wells Fargo to $57 from $55 Overweight - $CNTA -Oppenheimer raises Centessa Pharmaceuticals target to $62 from $40 Outperform - $COF -Jefferies raises CapitalOne target to $275 from $265 Buy - https://twitter.com/i/web/status/1998816114546192458 https://twitter.com/i/web/status/1998816114546192458"
X Link 2025-12-10T18:04Z [----] followers, [---] engagements

"$NPCE -JPMorgan raises NeuroPace target to $20 from $18 Overweight - $NRIX -HC Wainwright raises Nurix Therapeutics target to $31 from $28 Buy -Mizuho lifts target to $30 from $24 Outperform - $NUE -Jefferies raises Nucor target to $190 from $170 Buy -"
X Link 2025-12-10T22:58Z [----] followers, [---] engagements

"$VALE -RBC raises Vale target to $14.20 from $11 Upgrades to Outperform from Sector Perform - $VLTO -Jefferies lowers Veralto target to $105 from $125 Downgrades to Hold from Buy - $VRDN -Wedbush raises Viridian Therapeutics target to $47 from $42 Outperform -"
X Link 2025-12-11T01:00Z [----] followers, [---] engagements

"$TNYA Tenaya Therapeutics Reports Positive Interim Data from Cohort [--] of RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC - Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week [--] - Clinically Meaningful Reductions in Arrhythmia Burden Observed in First Two Patients with More Than Six Months of Follow-Up - Tenaya Management to Host a Webcast Conference Call Thursday December [--] at 5:00 pm ET to Review Preliminary Results"
X Link 2025-12-11T21:05Z [----] followers, [---] engagements

"$IKT -Cantor Fitzgerald initiates Inhibikase Therapeutics coverage at Overweight $4 target - $INSM -Cowen raises Insmed target to $269 from $231 Buy - $IONQ -Mizuho initiates IonQ coverage at Outperform $90 target https://www.investing.com/news/analyst-ratings/ionq-stock-initiated-at-outperform-by-mizuho-with-90-price-target-93CH-4402619 https://www.investing.com/news/analyst-ratings/ionq-stock-initiated-at-outperform-by-mizuho-with-90-price-target-93CH-4402619"
X Link 2025-12-11T22:29Z [----] followers, [---] engagements

"$LBRX -Stifel raises LB Pharmaceuticals target to $35 from $27 Buy - $LEG -Piper Sandler lifts Leggett & Platt target to $12 from $10 Neutral - $LII -Barclays lowers Lennox target to $680 from $700 Overweight - $LNG -Bank of America lowers Cheniere Energy target to $271 from $274 Buy https://twitter.com/i/web/status/1999253954048512060 https://twitter.com/i/web/status/1999253954048512060"
X Link 2025-12-11T23:04Z [----] followers, [---] engagements

"$TNYA Tenaya Therapeutics Announces Pricing of Public Offering The offering is comprised of [--------] units at a public offering price of $1.20 per unit with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $1.50 per share. https://www.stocktitan.net/news/TNYA/tenaya-therapeutics-announces-pricing-of-public-es028g28ab9v.html https://www.stocktitan.net/news/TNYA/tenaya-therapeutics-announces-pricing-of-public-es028g28ab9v.html"
X Link 2025-12-12T06:57Z [----] followers, [---] engagements

"$MCS -Barrington Research maintains Marcus $25 target Outperform - $MGY -Mizuho upgrades Magnolia Oil to Outperform from Neutral Raises target to $29 from $26 - $MNST -Stifel raises Monster Beverage target to $82 from $78 Buy - $MPC -Mizuho raises Marathon Petroleum target to $196 from $188 Neutral - https://twitter.com/i/web/status/2000013493123330058 https://twitter.com/i/web/status/2000013493123330058"
X Link 2025-12-14T01:22Z [----] followers, [---] engagements

"$NOG -Mizuho raises Northern Oil target to $30 from $28 Neutral - $NTSK -KeyBanc raises Netskope target to $28 from $27 Overweight -Piper Sandler reiterates $28 target Overweight -RBC raises target to $27 from $26 Outperform -Deutsche Bank to $26 from $25 Buy -Mizuho to $26 from $25 Outperform - https://twitter.com/i/web/status/2000019704149315678 https://twitter.com/i/web/status/2000019704149315678"
X Link 2025-12-14T01:47Z [----] followers, [---] engagements

"$PNW -KeyBanc downgrades Pinacle West Capital to Sector Weight from Overweight - $POR -JPMorgan raises Portland General Electrictarget to $49 from $47 Neutral - $PPL -Wells Fargo raises PPL target to $45 from $43 Overweight -"
X Link 2025-12-14T15:55Z [----] followers, [---] engagements

"$RHI -Truist lowers Robert Half target to $35 from $50 Buy - $RIVN -Needham raises Rivian target to $23 from $14 Buy -Goldman lifts target to $16 from $13 Neutral - $RL -Jefferies raises Ralph Lauren target to $425 from $385 Buy -"
X Link 2025-12-14T16:25Z [----] followers, [---] engagements

"$RLAY -Wells Fargo upgrades Relay Therapeutics to Overweight from = Weight Raises target to $13 from $6 - $RMD -UBS raises ResMed target to $345 from $335 Buy - $ROIV -HC Wainwright raises Roivant Sciences target to $26 from $23 Buy -"
X Link 2025-12-14T16:28Z [----] followers, [---] engagements

"$WSO -KeyBanc maintains Watsco Sector Weight rating - $WTS -Jefferies initiates Watts Water Technologies coverage at Hold $300 target - $WTW -Keefe Bruyette & Woods raises Willis Towers Watson target to $375 from $373 Outperform -Wells Fargo lowers target to$356 from$362 Overweight - https://twitter.com/i/web/status/2000254464796840268 https://twitter.com/i/web/status/2000254464796840268"
X Link 2025-12-14T17:20Z [----] followers, [---] engagements

"$LMRI Lumexa Imaging tallies $462.5M in IPO doubling original target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target"
X Link 2025-12-15T16:01Z [----] followers, [---] engagements

"$EVTL -Needham raises Vertical Aerospace to $11 from $9 Buy - $EXPO -UBS raises Exponent target to $81 from $76 Neutral - $FAST -Jefferies raises Fastenal target to $52 from $45 Upgrades to Buy from Hold -UBS lifts target to $52 from $45 Upgrades to Buy from Neutral -"
X Link 2025-12-15T20:30Z [----] followers, [---] engagements

"$GOLF -JPMorgan raises Acushnet target to $474 from $67 Underweight - $GSBD -Lucid Capital initiates Goldman Sachs BDC coverage with a Neutral rating $10.50 target - $GTM -KeyBanc upgrades ZoomInfo Technologies to Sector Weight from Underweight -"
X Link 2025-12-15T22:15Z [----] followers, [---] engagements

"$MRK -Bank of America raises Merck & Co. target to $120 from $105 Buy - $MRVI -Wells Fargo raises Maravai Life Sciences target to $4.50 from $4 Overweight - $MSFT -Wolfe Research lowers Microsoft target to $625 from $675 Outperform - $MSGE $MSGS -Wolfe Research downgrades Madison Square Garden Entertainment and Madison Square Sports to Peer Perform from Outperform - https://twitter.com/i/web/status/2000738330187796951 https://twitter.com/i/web/status/2000738330187796951"
X Link 2025-12-16T01:22Z [----] followers, [---] engagements

"$POOL -Wells Fargo lowers Pool target to $250 from $320 = Weight - $PRAX -Oppenheimer raises Praxis Precision Medicines target to $750 from $250 Outperform - $PRGO -JPMorgan lowers Perrigo target to $18 from $20 Neutral - $PRI -Morgan Stanley lowers Primerica target to $292 from $301 = Weight - https://twitter.com/i/web/status/2000746388553130323 https://twitter.com/i/web/status/2000746388553130323"
X Link 2025-12-16T01:54Z [----] followers, [---] engagements

"$SCCO -Morgan Stanley raises Southern Copper target to $138 from $130 Downgrades to Underweight from = Weight - $SDGR -Bank of America upgrades Schrodinger to Buy from Neutral as company refocuses business strategy on software operations https://www.investing.com/news/analyst-ratings/bofa-securities-upgrades-schrodinger-stock-rating-to-buy-from-neutral-93CH-4408063 https://www.investing.com/news/analyst-ratings/bofa-securities-upgrades-schrodinger-stock-rating-to-buy-from-neutral-93CH-4408063"
X Link 2025-12-16T02:21Z [----] followers, [---] engagements

"$INBX Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program - INBRX-106 has enrolled [--] of [--] randomized patients in the Phase [--] portion for first-line unresectable/metastatic HNSCC and expects to finish Phase [--] enrollment in Q1 [----]. - A separate Phase 1/2 checkpoint inhibitor refractory/relapsed NSCLC cohort completed enrollment at [--] patients in November [----]. - Current datasets lack maturity to support conclusions; maturity expected in 2H [----] to inform efficacy versus standard of care. - Ozekibart (INBRX-109)"
X Link 2025-12-16T22:19Z [----] followers, [---] engagements

"$CTVA -Goldman raises Corteva target to $78 from $77 Buy - $CUBE -Truist lowers CubeSmart target to $42 from $48 Buy - $CW -Morgan Stanley raises Curtiss-Wright target to $660 from $645 Overweight -Stifel lowers target to $584 from $587 Hold - g"
X Link 2025-12-16T23:37Z [----] followers, [---] engagements

"$INSM Wells Fargo raises Insmed target to $234 from $217 Overweight -Cantor Fitzgerald lifts target to $230 from $216 Overweight - $INSP -JPMorgan raises Inspire Medical; Systems target to $118 from $82 Neutral - $INVA -HC Wainwright raises Innoviva target to $46 from $45 Buy -"
X Link 2025-12-17T00:57Z [----] followers, [---] engagements

"$KYMR -RBC raises Kymera Therapeutics target to $103 from $70 Outperform - $KYTX -Wells Fargo raises Kyverna Therapeutics target to $33 from $31 Overweight - $LAMR -Morgan Stanley raises Lamar Advertising target to $140 from $135 = Weight -"
X Link 2025-12-17T01:42Z [----] followers, [---] engagements

"$LECO -Stifel lowers Lincoln Electric target to $252 from $265 Hold - $LIF -Canaccord reiterates Life360 $115 target Buy - $LINE -Morgan Stanley lowers Lineage target to $39 from $46 = Weight - $LIVN -Baird lifts LivaNova target to $75 from $70 Outperform -"
X Link 2025-12-17T01:44Z [----] followers, [---] engagements

"$MDT -Baird lowers Medtronic target to $103 from $109 Neutral - $MIRM -Stifel raises Mirum Pharmaceuticals target to $98 from $92 Buy - $MIST -Wells Fargo raises Milestone Pharmaceuticals target to $8 from $4 Overweight - $MKSI -Cantor Fitzgerald raises MKS target to $200 from $180 Overweight - https://twitter.com/i/web/status/2001110485417205988 https://twitter.com/i/web/status/2001110485417205988"
X Link 2025-12-17T02:01Z [----] followers, [---] engagements

"$PONY -Barclay starts Pony AI coverage with an = Weight rating $15 target - $POOL -Stifel lowers Pool target to $240 from $295 Hold - $PROK -HC Wainwright initiates ProKidney coverage with a Buy rating $12 target -"
X Link 2025-12-17T04:05Z [----] followers, [---] engagements

"$ROST -Wells Fargo raises Ross Stores target to $200 from $180 Overweight - $RPD -Jefferies trims Rapid7 target to $18 from $19 Hold - $RSI -Susquehanna lifts Rush Street target to $23 from $22 Positive - $RXO -Stifel lifts RXO target to $16 from $15 Hold -"
X Link 2025-12-17T04:48Z [----] followers, [---] engagements

"$WMT -Evercore raises Walmart target to $120 from $117 Outperform - $WRB -Morgan Stanley lowers W.R. Berkley target to $75 from $80 = Weight - $WRBY -Piper Sandler raises Warby Parker target to $32 from $22 Overweight -"
X Link 2025-12-17T05:39Z [----] followers, [---] engagements

"$WYFI -Compass Point initiates WhiteFiber coverage with a Buy rating $32 target - $XPO -Stifel raises XPO target to $167 from $149 Buy - $XRAY -Barrington Research lowers Dentsply Sirona target to $14 from $18 Outperform -Baird trims target to $12 from $14 Neutral -"
X Link 2025-12-17T05:43Z [----] followers, [---] engagements

"$WST West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector via @Barchart https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector"
X Link 2025-12-17T16:32Z [----] followers, [---] engagements

"$RCT RedCloud Delivers Record [----] Executes $50m Turkiye License and Accelerates Toward $100m Revenue in [----] https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html"
X Link 2025-12-17T22:12Z [----] followers, [---] engagements

"$EQH BMO reiterates Equitable $69 target Outperform - $ES -UBS lowers Eversource Energy target to $73 from $78 Neutral - $ESTA -Mizuho raises Establishment Labs target to $90 from $85 Outperform -Canaccord to $85 from $72 Buy -JPMorgan to $80 from $71 Overweight -"
X Link 2025-12-17T23:15Z [----] followers, [---] engagements

"$LEGN -Cantor Fitzgerald trims Legend Biotech target to $74 from $75 Overweight - $LEN -RBC downgrades Lennar to Underperform from Sector Perform - $LITE -Morgan Stanley raises Lumentum target to $304 from $190 = Weight - $LIVN -Mizuho raises LivaNova target to $72 from $70 Outperform - https://twitter.com/i/web/status/2001445275098059226 https://twitter.com/i/web/status/2001445275098059226"
X Link 2025-12-18T00:11Z [----] followers, [---] engagements

"$SMMT -Barclays raises Summit Therapeutics target to $18 from $16 Upgrades to = Weight from Underweight - $SMWB -Oppenheimer lowers Similarweb target to $10 from $12 Outperform - $SNX -Morgan Stanley lowers TD SYNNEX target to $177 from $181 Overweight -"
X Link 2025-12-18T03:32Z [----] followers, [---] engagements

"$TDC -Morgan Stanley raises Teradata target to $35 from $30 Overweight - $TEF -New Street downgrades Telefonica to Reduce from Neutral [----] target - $TENX -Guggenheim maintains Tenax Therapeutics $25 target Buy -"
X Link 2025-12-18T03:53Z [----] followers, [---] engagements

"$TFC -Morgan Stanley raises Truist Financial target to $56 from $55 = Weight -Keefe Bruyette & Woods lift target to $53 from $49 Market Perform - $TFX -RBC raises Teleflex target to $135 from $120 Sector Perform - $TJX -Baird raises TJX Companies target to $168 from $165 Outperform - https://twitter.com/i/web/status/2001501692404338743 https://twitter.com/i/web/status/2001501692404338743"
X Link 2025-12-18T03:56Z [----] followers, [---] engagements

"$ULTA -Baird raises Ulta Beauty target to $700 from $670 Outperform - $UPB -Mizuho starts Upstream Bio coverage at Outperform -Sets $51 target http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html"
X Link 2025-12-18T04:09Z [----] followers, [---] engagements

"$WSBC -Piper Sandler initiates WesBanco coverage with an Overweight rating $42 target - $WT -Morgan Stanley raises WisdomTree target to $14.75 from $13.50 = Weight - $WTRG -Barclays downgrades Essential Utilities to Underweight from Overweight Lowers target to $38 from $43 -"
X Link 2025-12-18T05:17Z [----] followers, [---] engagements

"$XEL -UBS lowers Xcel Energy target to $81 from $86 Neutral - $XNCR -Barclays raises Xencor target to $26 from $23 Overweight - $YOU -Telsey raises Clear Secure target to $45 from $38 Outperform - $ZYME -Truist reiterates Zymeworks Buy rating $40 target --"
X Link 2025-12-18T05:19Z [----] followers, [---] engagements

"$CLYM -HC Wainwright raises Climb Bio target to $11 from $9 Buy - $CMCSA -UBS maintains Comcast $36 target Neutral - $CMI -Truist raises Cummins target to $653 from $628 Buy - $CNK -Morgan Stanley lowers Cinemark target to $28 from $35 Downgrades to = Weight from Overweight -"
X Link 2025-12-18T20:03Z [----] followers, [---] engagements

"$CRL -Mizuho raises Charles River Laboratories target to $200 from $174 Neutral - $CRVO -HC Wainwright reiterates CervoMed $25 target Buy -Cantor Fitzgerald initiates coverage with an Overweight rating citing promising data from two Phase [--] studies https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-cervomed-stock-with-overweight-rating-93CH-4414813 https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-cervomed-stock-with-overweight-rating-93CH-4414813"
X Link 2025-12-18T20:44Z [----] followers, [---] engagements

"$DAL -Wells Fargo initiates Delta Air Lines coverage at Overweight $87 target - $DBVT -HC Wainwright raises DBV Technologies target to $40 from $35 Buy - $DD -Mizuho raises DuPont target to $46 from $44 Outperform - $DHR -KeyBanc reiterates Danaher $310 target Overweight -"
X Link 2025-12-18T20:53Z [----] followers, [---] engagements

"$EMN -Citi raises Eastman Chemical target to $72 from $70 Buy - $EQIX -Goldman lowers Equinix target to $795 from $910 Downgrades to Neutral from Buy - $ETN -Wells Fargo lowers Eaton target to $340 from $395 = Weight -"
X Link 2025-12-18T21:10Z [----] followers, [---] engagements

"$GBCI -Piper Sandler raises Glacier Bancorp target to $58 from $50 Upgrades to Overweight from Neutral - $GDRX -Morgan Stanley lowers GoodRx target to $4 from $5 = Weight - $GEV -Baird raises GE Verona target to $816 from $706 Outperform -Jefferies lifts target to $815 from $736 Upgrades to buy from Hold - https://twitter.com/i/web/status/2001847642322801063 https://twitter.com/i/web/status/2001847642322801063"
X Link 2025-12-19T02:50Z [----] followers, [---] engagements

"$PRCT -Truist lowers PROCEPT BioRobotics target to $47 from $50 Buy - $PSA -JPMorgan lowers Public Storage target to $301 from $316 Downgrades to Neutral from Overweight - $PYXS -RBC lowers Pyxis Oncology target to $5 from $8 Outperform -"
X Link 2025-12-19T05:32Z [----] followers, [---] engagements

"$RPM -MIzuho lowers RPM International target to $128 from $138 Outperform -Citi to $127 from $136 Buy -UBS to $119 from $127 Neutral - $RTO -Bank of America raises Rentokil Initial target to $34 from $28 Upgrades to Buy from Neutral - $RYN -RBC lowers Rayonier target to $25 from $27 Sector Perform - https://twitter.com/i/web/status/2001895913451868359 https://twitter.com/i/web/status/2001895913451868359"
X Link 2025-12-19T06:02Z [----] followers, [---] engagements

"$WLK -Citi raises Westlake target to $85 from $75 Buy - $ZBRA -Truist lowers Zebra Technologies target to $291 from $331 Hold - $ZS -Morgan Stanley lowers Zscaler target to $305 from $335 Overweight - $ZTS -Morgan Stanley lowers Zoetis target to $160 from $175 Overweight --"
X Link 2025-12-19T06:33Z [----] followers, [---] engagements

"$INAB IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager https://www.stocktitan.net/news/INAB/in8bio-announces-pricing-of-private-placement-of-up-to-40-2-million-m0tfyux0ggs5.html https://www.stocktitan.net/news/INAB/in8bio-announces-pricing-of-private-placement-of-up-to-40-2-million-m0tfyux0ggs5.html"
X Link 2025-12-19T16:06Z [----] followers, [---] engagements

"$AMPL -Baird lifts Amplitude target to $15 from $14 Outperform - $APD -Wells Fargo lowers Air Products target to $250 from $330 Downgrades to = Weight from Overweight - $APH -Truist raises Amphenol target to $180 from $147 Buy -"
X Link 2025-12-20T16:01Z [----] followers, [---] engagements

"$MLYS -Stifels raises Mineralys Therapeutics target to $52 from $45 Buy - $MNST -Bank of America raises Monster Beverage target to $85 from $77 Buy - $MPWR -Truist raises Monolithic Power target to $1375 from $1163 Buy - $MTDR -KeyBanc maintains Matador Resources $52 target Overweight - https://twitter.com/i/web/status/2002489219076534682 https://twitter.com/i/web/status/2002489219076534682"
X Link 2025-12-20T21:20Z [----] followers, [---] engagements

"$TTAM -Bernstein raises Titan America target to $17 from $15 Market Perform - $TTMI -Truist raises TTM Technologies target to $91 from $78 Buy - $TXN -Truist raises Texas Instruments target to $195 from $175 Hold - $UBER -Wedbush lowers Uber target to $78 from $84 Neutral -0"
X Link 2025-12-20T23:26Z [----] followers, [---] engagements

"$AVIR Atea Pharmaceuticals Completes Patient Enrollment in North American Phase [--] Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-north-american-wbapc081xczz.html https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-north-american-wbapc081xczz.html"
X Link 2025-12-22T16:01Z [----] followers, [---] engagements

"$ACLX -Wells Fargo initiates Arcellx coverage at Overweight viewing company's anito-cel therapy as a 'future pillar in multuple myeloma management' -Sets $100 target https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-coverage-on-arcellx-stock-with-overweight-rating-93CH-4418972 https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-coverage-on-arcellx-stock-with-overweight-rating-93CH-4418972"
X Link 2025-12-22T20:31Z [----] followers, [---] engagements

"$ADEA -Roth reiterates Adeia $27 target Buy -Rosenblatt raises target to $20 from $17 Buy - $AFL -Cowen raises Aflac target to $102 from $100 Hold - $AGNC -Piper Sandler raises AGNC Investment target to $11 from $10.50 Overweight -"
X Link 2025-12-22T20:39Z [----] followers, [---] engagements

"$FITB -Truistr raises Fifth Third Bank target to $55 from $50 Buy - $FLUT -Truist lowers Flutter Entertainment target to $280 from $305 Buy - $FMC -KeyBanc maintains FMC Sector Weight rating - $FN -Northland raises Fabrinet target to $600 from $550 Outperform -"
X Link 2025-12-22T22:09Z [----] followers, [---] engagements

"$LW -Bank of America lowers Lamb Weston target to $53 from $66 Neutral -Stifel to $50 from $63 Hold -Deutsche Bank to $49 from $61 Hold -BNP Paribas to $48 from $66 Downgrades to Neutral from Outperform - $MCK -Cowen reiterates McKesson $1000 target Buy -"
X Link 2025-12-22T23:44Z [----] followers, [---] engagements

"$RC -Piper Sandler lowers Ready Capital target to #4.50 from $3.50 Neutral - $REXR -Evercore trims Rexford Industrial target to $40 from $41 In-Line - $RF -Truist raises Regions Financial target to $29 from $26 Hold - $RJF -Morgan Stanley raises Raymond James Financial target to $187 from $185 = Weight - https://twitter.com/i/web/status/2003266424765387164 https://twitter.com/i/web/status/2003266424765387164"
X Link 2025-12-23T00:48Z [----] followers, [---] engagements

"$SEE -Raymond James downgrades Sealed Air to Market Perform from Outperform -' $SIGI -Piper Sandler raises Selective Insurance target to $179 from $176 Neutral - $SLGL -HC Wainwright maintains Sol-Del Technologies $50 target Buy - $SMR -B. Riley lowers NuScale Power target to $24 from $38 Buy - https://twitter.com/i/web/status/2003268635465515428 https://twitter.com/i/web/status/2003268635465515428"
X Link 2025-12-23T00:57Z [----] followers, [---] engagements

"$OLMA $OPNT [--] people charged in $41M insider trading scheme tied to [--] biotechs https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme"
X Link 2025-12-23T01:14Z [----] followers, [---] engagements

"$TEAD -Needham maintains Teads $1 target Buy - $TEM -Canaccord lowers Tempus AI target to $80 from $95 Buy - $TEVA -Piper Sandler raises Teva Pharmaceuticals target to $40 from $30 Overweight - $TFII -RBC raises TFI International target to $125 from $102 Outperform -"
X Link 2025-12-23T01:37Z [----] followers, [---] engagements

"$TLX -HC Wainwright maintains Telix Pharmaceuticals $20 target Buy - $TMDX -Piper Sandler reiterates TransMedics $140 target Buy - $TME -Morgan Stanley lowers Tencent Music target to $25 from $27.50 Overweight - $TMUS -Bernstein maintains T-Mobile $265 target Neutral -"
X Link 2025-12-23T01:39Z [----] followers, [---] engagements

"$WGS -Canaccord lifts GeneDX target to $170 from $160 Buy - $WHWK -Jones Trading initiates Whitehawk Therapeutics with a Buy rating highlighting three antibody drug conjugates in-licensed from WuXi Biologics -Sets $7 target https://www.investing.com/news/analyst-ratings/jones-trading-initiates-coverage-on-whitehawk-therapeutics-stock-with-buy-rating-93CH-4419921 https://www.investing.com/news/analyst-ratings/jones-trading-initiates-coverage-on-whitehawk-therapeutics-stock-with-buy-rating-93CH-4419921"
X Link 2025-12-23T01:51Z [----] followers, [---] engagements

"$AME -Cowen raises AMETEK target to $230 from $190 Upgrades to Buy from Hold - $AMPX -Oppenheimer maintains Amprius Technologies $17 target Outperform - $ANNX -Chardan Capital reiterates Annexon $16 target Buy - $ARCB -Bank of America raises ArcBest target to $84 from $72 Buy -"
X Link 2025-12-23T22:28Z [----] followers, [---] engagements

"$CNO -Piper Sandler raises CNO Financial target to $50 from $46 Overweight - $COTY -Santander downgrades Coty to Neutral from Outperform $3.50 target - $COYA -D. Boral maintains Coya Therapeutics $15 target Buy -"
X Link 2025-12-23T22:43Z [----] followers, [---] engagements

"$MNST -Morgan Stanley raises Monster Beverage target to $87 from $81 Overweight - $MTN -Morgan Stanley trims Vail Resorts target to $151 from $153 = Weight - $NAVN -Citizens JMP reiterates Navan $25 target Market Outperform - $NICE -Rosenblatt maintains NiCE $175 target Buy -"
X Link 2025-12-23T23:21Z [----] followers, [---] engagements

"$WGO -Benchmark raises Winnebago target to $48 from $42 Buy - $WLK -UBS trims Westlake target to $92 from $93 Overweight - $WSM -Evercore raises Williams Sonoma target to $195 from $190 In-Line --"
X Link 2025-12-23T23:56Z [----] followers, [---] engagements

"$DOMO -Cantor Fitzgerald reiterates Domo $22 target Overweight - $DTE -BMO lowers DTE Energy target to $148 from $151 Market Perform - $EOLS -Needham maintains Evolus Hold rating - $EPM -Freedom Capital initiates Evolution Petroleum with a Buy rating $5.30 target -"
X Link 2025-12-24T18:03Z [----] followers, [---] engagements

"$ICCC ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain ImmuCell pauses further internal investment in ReTain after an FDA Incomplete Letter and redirects resources to the First Defense franchise. The company expects a noncash impairment of about $2.3M against ReTain assets with a $15.5M net book value while expanding sales and manufacturing for First Defense. https://www.stocktitan.net/news/ICCC/immu-cell-announces-strategic-focus-on-first-defense-after-receiving-rf7gftwv4t14.html"
X Link 2025-12-24T19:55Z [----] followers, [---] engagements

"$CELH $GURU $MNST $PEP $STBFY Best Energy Drink Stocks WarrenAI Says to Buy for 2026: From Monster to Celsius https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709 https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709"
X Link 2025-12-24T23:23Z [----] followers, [---] engagements

"$IKT -HC Wainwright assumes Inhibikase coverage with a Buy rating as company plans to advance its lead candidate IKT-001 -Sets $8 target https://www.investing.com/news/analyst-ratings/hc-wainwright-assumes-coverage-on-inhibikase-stock-with-buy-rating-93CH-4423069 https://www.investing.com/news/analyst-ratings/hc-wainwright-assumes-coverage-on-inhibikase-stock-with-buy-rating-93CH-4423069"
X Link 2025-12-27T00:22Z [----] followers, [---] engagements

"$RPRX $RHHBY Royalty Pharma Acquires Remaining Royalty Interest in Roches Evrysdi for $240 Million and Potential Milestones Evrysdi marketed by Roche is an orally administered survival motor neuron-2 (SMN2) splicing modifier for the treatment of spinal muscular atrophy. Evrysdi was approved by the FDA in [----] and has treated over [-----] patients worldwide. In [----] Evrysdi generated sales of approximately CHF [---] billion ($1.9 billion) representing 18% year-over-year growth at constant exchange rates and is projected to reach CHF [---] billion ($2.9 billion) of sales by [----] based on analyst"
X Link 2025-12-30T01:35Z [----] followers, [---] engagements

"$BMR Beamr Completes SOC [--] Audit Reinforcing Enterprise-Grade Security and Privacy Operations https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html"
X Link 2025-12-30T15:14Z [----] followers, [---] engagements

"$AAON -William Blair reiterates AAON Outperform rating - $AFL -Raymond James raises Aflac target to $119 from $110 Outperform - $AIRE -HC Wainwright maintains reAlpha Tech $2 target Buy https://www.investing.com/news/analyst-ratings/realpha-tech-stock-maintains-buy-rating-at-hc-wainwright-following-instamortgage-acquisition-93CH-4425241 https://www.investing.com/news/analyst-ratings/realpha-tech-stock-maintains-buy-rating-at-hc-wainwright-following-instamortgage-acquisition-93CH-4425241"
X Link 2025-12-30T23:40Z [----] followers, [---] engagements

"$CVLT -Stephens initiates CommVault coverage with an Overweight rating $162 target - $DECK -UBS maintains Deckers Outdoor $157 target Buy - $DNLI -Jefferies maintains Denali Therapeutics $40 target Buy - $DRUG -HC Wainwright reiterates Bright Minds Biosciences $115 target Buy -"
X Link 2025-12-30T23:57Z [----] followers, [---] engagements

"$TWLO -Citizens JMP raises Twilio target to $185 from $165 Market Outperform - $UNCY -Guggenheim reiterates Unicycive Buy rating amid NDA resubmission -Maintains $46 target https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234 https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234"
X Link 2025-12-31T00:51Z [----] followers, [---] engagements

"$WTFC -Citi raises Wintrust Financial target to $167 from $159 Buy - $ZVRA -HC Wainwright maintains Zevra Therapeutics Buy rating on expanded access deal -Maintains $26 target -- https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240 https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240"
X Link 2025-12-31T00:57Z [----] followers, [---] engagements

"$WSP -BMO raises WSP Global target to C$336 from C$335 Outperform - $WULF Keefe Bruyette & Woods raise TeraWulf target to $24 from $9.50 Upgrade to Outperform from Market Perform https://stocktwits.com/news-articles/markets/equity/wulf-stock-rises-3-percent-pre-market-after-keefe-more-than-doubles-price-target/cL7B7PaREzF https://stocktwits.com/news-articles/markets/equity/wulf-stock-rises-3-percent-pre-market-after-keefe-more-than-doubles-price-target/cL7B7PaREzF"
X Link 2025-12-31T18:54Z [----] followers, [---] engagements

"$AMSC $MGY $PBW $XOP Clear Street Names American Superconductor and Magnolia Oil & Gas as Top [----] Picks https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616 https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616"
X Link 2026-01-02T18:35Z [----] followers, [---] engagements

"$ECVT -BWS reiterates Ecovyst $12 target Buy - $ESNT -Roth raises Essent Group target to $75 from $70 Buy - $FBLG -HC Wainwright maintains FibroBiologics $5 target Buy - $GKOS -Stephens raises Glaukos target to $145 from $115 Overweight -BTIG maintains $116 target Buy -"
X Link 2026-01-02T18:59Z [----] followers, [---] engagements

"$HOLO MicroCloud Hologram Inc. Launches Q-DPC Accelerator: Quantum-Empowered Density Peak Clustering's Strategy Evaluation Performance Leap Solution https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html"
X Link 2026-01-02T21:09Z [----] followers, [---] engagements

"- $A -Evercore upgrades Agilent Technologies to Outperform from In-Line $160 target - $ABT -Barclays raises Abbott target to $169 from $162 Overweight - $ACAD -Needham raises ACADIA Pharmaceuticals target to $34 from $29 Buy - $ACN -Rothschild Redburn raises Accenture target to $210 from $205 Neutral - https://twitter.com/i/web/status/2008229319882207288 https://twitter.com/i/web/status/2008229319882207288"
X Link 2026-01-05T17:29Z [----] followers, [---] engagements

"$AIRO -Mizuho lowers AIRO target to $20 from $25 Outperform - $AKAM -RBC raises Akamai target to $90 from $80 Sector Perform -Piper Sandler lifts target to $89 from $86 Neutral - $AKTX -Ladenburg Thalman initiates Akari Therapeutics coverage with a Buy rating $1 target -"
X Link 2026-01-05T17:33Z [----] followers, [---] engagements

"$CRAI -Barrington Research raises Charles River target to $245 from $239 Outperform - $CRBG -JPMorgan trims Corebridge Financial target to $39 from $40 Neutral - $CRC -RBC raises California Resources target to $70 from $60 Outperform - $CRCL -Goldman raises Circle Internet target to $88 from $79 Neutral - https://twitter.com/i/web/status/2008274433824436584 https://twitter.com/i/web/status/2008274433824436584"
X Link 2026-01-05T20:28Z [----] followers, [---] engagements

"$CSV -Barrington Research reiterates Carriage Services $60 target Outperform - $CVLT -Piper Sandler lowers Commvault target to $155 from $186 Overweight - $CVNA -Gordon Haskett lowers Carvana target to $435 from $445 Hold -"
X Link 2026-01-05T20:36Z [----] followers, [---] engagements

"$CVX -Citi lowers Chevron target to $179 from $185 Buy -Bernstein raises target to $172 from $170 Market Perform - $CYH -Truist trims Community Health Systems target to $4 from $4.50 Hold - $DBX _RBC lowers Dropbox target to $35 from $38 Outperform -"
X Link 2026-01-05T20:38Z [----] followers, [---] engagements

"$DMAC -Lake Street initiates DiaMedica Therapeutics coverage with a Buy rating $14 target - $DOC -Cantor lowers Healthpeak Properties target to $17 from $20 Neutral - $DOCN -Piper Sandler raises DigitalOcean target to $50 from $47 Neutral - $DOCU -RBC lowers DocuSign target to $70 from $95 Sector Perform - https://twitter.com/i/web/status/2008278965467951131 https://twitter.com/i/web/status/2008278965467951131"
X Link 2026-01-05T20:46Z [----] followers, [---] engagements

"$DPZ -Cowen lowers Domino's Pizza target to $460 from $500 Downgrades to Hold from Buy - $DT -RBC lowers Dynatrace target to $56 from $64 Outperform -Jefferies cuts target to $55 from $65 Buy - $DUOL -Bank of America lowers Duolingo target to $250 from $301 Upgrades to Buy from Neutral - https://twitter.com/i/web/status/2008279624103719387 https://twitter.com/i/web/status/2008279624103719387"
X Link 2026-01-05T20:49Z [----] followers, [---] engagements

"$ELV -Barclays raises Elevance Health target to $404 from $385 Overweight - $EMR -UBS raises Emerson Electric target to $168 from $131 Upgrades to Buy from Neutral - $ENOV -UBS lowers Enovis target to $50 from $57 Buy -Evercore cuts target to $40 from $44 Outperform -"
X Link 2026-01-05T20:58Z [----] followers, [---] engagements

"$EPC -Wells Fargo lowers Edgewell Personal Care target to $20 from $23 Overweight - $EPD -Raymond James downgrades Enterprise Product Partners to Outperform from Strong Buy $36 target - $EQH -JPMorgan upgrades Equitable to Overweight from Neutral Lowers target to $60 from $64 -"
X Link 2026-01-06T00:26Z [----] followers, [---] engagements

"$EQT -Bernstein lifts EQT target to $73 from $72 Outperform - $ESTC -RBC lowers Elastic target to $95 from $115 Outperform -Jefferies cuts target to $95 from $105 Buy - $ETOR -Goldman lowers eToro target to $39 from $48 Downgrades to Neutral from Buy -"
X Link 2026-01-06T00:28Z [----] followers, [---] engagements

"$GTLB -Piper Sandler lowers GitLab target to $55 from $70 Overweight -RBC cuts target to $48 from $58 Outperform - $HBAN -Barclays lifts Huntington Bancshares target to $20 from $19 = Weight - $HESM -Raymond James downgrades Hess Midstream to Market Perform from Outperform -"
X Link 2026-01-06T01:14Z [----] followers, [---] engagements

"$HII -Melius upgrades Huntington Ingalls to Buy from Hold - $HIMS -Citi maintains Hims & Hers Health $30 target Sell - $HNGE -Barclays lowers Hinge Health target to $60 from $65 Overweight - $HOLX -Evercore trims Hologic target to $78 from $79 Downgrades to In-Line from Outperform - https://twitter.com/i/web/status/2008348357165805981 https://twitter.com/i/web/status/2008348357165805981"
X Link 2026-01-06T01:22Z [----] followers, [---] engagements

"$MNDY -Jefferies lowers target to $260 from $300 Buy - $MNMD -Needham adds Mind Medicine to Conviction List names stock as a top pick Reiterates Buy rating $28 target - $MNST -Wells Fargo raises Monster Beverage target to $86 from $83 Overweight - http://monday.com http://monday.com"
X Link 2026-01-06T02:38Z [----] followers, [---] engagements

"$PNR -Cowen lowers Pentair target to $90 from $110 Downgrades to Sell from Hold - $PRAX -Needham raises Praxis Precision Medicines target to $460 from $315 Buy - $PRDO -Barrington Research reiterates Perdoceo Education $42 target Outperform -"
X Link 2026-01-06T05:45Z [----] followers, [---] engagements

"$RBLX -Wolfe Research lowers Roblox target to $100 from $150 Outperform - $RBRK -Piper Sandler cuts Rubrik target to $99 from $118 Overweight - $REG -Morgan Stanley raises Regency Centers target to $85 from $78 Overweight - $RF -Barclays raises Regions Financial target to $30 from $27 Underweight - https://twitter.com/i/web/status/2008416624223858930 https://twitter.com/i/web/status/2008416624223858930"
X Link 2026-01-06T05:53Z [----] followers, [---] engagements

"$RPD -Piper Sandler lowers Rapid7 target to $16 from $19 Neutral -RBC cuts target to $16 from $19 Sector Perform -Barclays lowers target to $15 from $18 Downgrades to Underweight from = Weight - $RSG -Bernstein raises Republic Services target to $220 from $205 Market Perform -"
X Link 2026-01-06T05:59Z [----] followers, [---] engagements

"$TCMD -Piper Sandler raises Tactile Medical target to $35 from $20 Upgrades to Overweight from Neutral - $TDC -RBC raises Teradata target to $32 from $23 Sector Perform - $TEAM -Piper Sandler lowers Atlassian target to $280 from $300 Overweight - $TECH -Evercore lowers Bio-Techne target to $62 from $68 Downgrades to In-Line from Outperform - https://twitter.com/i/web/status/2008423776363704519 https://twitter.com/i/web/status/2008423776363704519"
X Link 2026-01-06T06:21Z [----] followers, [---] engagements

"$TENB -Piper Sandler lowers Tenable target to $35 from $40 Overweight -Barclays cuts target to $28 from $33 = Weight - $TFC -Barclays raises Truist Financial target to $56 from $47 Downgrades to Underweight from = Weight - $TFII -Susquehanna raises TFI International target to $123 from $105 Positive - https://twitter.com/i/web/status/2008424542121980037 https://twitter.com/i/web/status/2008424542121980037"
X Link 2026-01-06T06:25Z [----] followers, [--] engagements

"$TMO -Evercore raises Thermo Fisher target to $650 from $610 Outperform - $TSHA -Wells Fargo raises Taysha Gene Therapies target to $11 from $8 Overweight - $TSM -Goldman raises Taiwan Semiconductor Manufacturing target to NT2330 from NT1720 Buy - $TT -UBS lowers Trane Technologies target to $520 from $544 Buy - https://twitter.com/i/web/status/2008425340620943461 https://twitter.com/i/web/status/2008425340620943461"
X Link 2026-01-06T06:28Z [----] followers, [---] engagements

"$UNH -Barclays raises UnitedHealth target to $391 from $386 Overweight - $UNM -Jefferies maintains Unum $115 target Buy - $UPWK -Jefferies raises Upwork target to $27 from $22 Buy - $URGN -D. Boral reiterates Urogen Pharma $33 target Buy -"
X Link 2026-01-06T06:36Z [----] followers, [---] engagements

"$USB -Barclays raises US anchor target to $65 from $56 Overweight - $VCYT -Guggenheim raises Veracyte target to $50 from $45 Buy - $VICI -Cantor Fitzgerald lowers VICI properties target to $33 from $35 Overweight - $VNDA -HC Wainwright raises Vanda Pharmaceuticals target to $22 from $20 Buy - https://twitter.com/i/web/status/2008428174313746538 https://twitter.com/i/web/status/2008428174313746538"
X Link 2026-01-06T06:39Z [----] followers, [---] engagements

"$ZBH -Evercore raises Zimmer Biomet target to $120 from $94 Upgrades to Outperform from In-Line - $ZBIO -Morgan Stanley cuts Zenas Biopharma target to $19 from $37 Downgrades to = Weight from Overweight - $ZION -Barclays raises Zions Bancorp target to $68 from $61 Underweight -"
X Link 2026-01-06T06:58Z [----] followers, [---] engagements

"$ARVN -Citi raises Arvinas target to $15 from $10 Upgrades to Buy from Neutral - $ATR -Wells Fargo downgrades AptarGroup target to = Weight from Overweight $133 target - $AVXL -D. Boral reiterates Anavex Life Sciences $24 target Buy -"
X Link 2026-01-06T16:12Z [----] followers, [---] engagements

"$ELV -Bernstein raises Elevance Health target to $431 from $412 Outperform - $ENOV -BTIG initiates Enovis coverage at Buy $41 target - $EPAM -Truist starts EPAM Systems coverage at Hold $220 target - $EQIX -Deutsche Bank initiates Equinix coverage at Buy $915 target -"
X Link 2026-01-06T20:10Z [----] followers, [---] engagements

"$GHRS -Canaccord raises GH Research target to $39 from $35 Buy -Needham raises target to $29 from $19 Buy - $GL -Evercore downgrades Globe Life to In-Line from Outperform $155 target - $GLOB -Truist initiates Globant coverage at Hold $72 target -"
X Link 2026-01-06T23:43Z [----] followers, [---] engagements

"$UAL -UBS raises United Airlines target to $145 from $142 Buy -Bank of America raises target to $130 from $120 Buy - $ULCC -Bank of America lowers Frontier Group target to $4 from $5 Downgrades to Underperform from Neutral - $ULTA -Barclays raises Ulta Beauty target to $680 from $647 Overweight - https://twitter.com/i/web/status/2008751695128678619 https://twitter.com/i/web/status/2008751695128678619"
X Link 2026-01-07T04:04Z [----] followers, [---] engagements

"$CSGP CoStar Group Provides Full Year [----] and Medium-Term Outlook with Significant Adjusted EBITDA Expansion https://www.stocktitan.net/news/CSGP/co-star-group-provides-full-year-2026-and-medium-term-outlook-with-3kj9gbvkqs0g.html https://www.stocktitan.net/news/CSGP/co-star-group-provides-full-year-2026-and-medium-term-outlook-with-3kj9gbvkqs0g.html"
X Link 2026-01-07T16:54Z [----] followers, [---] engagements

"$ACN -UBS maintains Accenture $320 target Buy - $AD -Citi raises Array Digital target to $63 from $37 Buy - $ADPT -Cowen lifts Adaptive Biotechnologies target to $20 from $19 Buy - $ALB -Baird raises Albemarle target to $210 from $113 Upgrades to Outperform from Neutral -"
X Link 2026-01-07T22:33Z [----] followers, [---] engagements

"$ALK -Citi raises Alaska Airlines target to $69 from $61 Buy - $ALL -Evercore lowers Allstate target to $225 from $233 In-Line - $ALLO -UBS initiates Allogene Therapeutics coverage with a Buy rating highlighting [--] key upcoming catalysts -Sets $8 target https://www.investing.com/news/analyst-ratings/ubs-initiates-coverage-on-allogene-stock-with-buy-rating-8-price-target-93CH-4434009 https://www.investing.com/news/analyst-ratings/ubs-initiates-coverage-on-allogene-stock-with-buy-rating-8-price-target-93CH-4434009"
X Link 2026-01-07T22:41Z [----] followers, [---] engagements

"$ASND -Cowen maintains Ascends Pharma $325 target Buy - $ASTS -Scotiabank downgrades AST Spacemobile to Sector Underperform from Sector Perform $45.60 target - $AVTR -Cowen lowers Avantor target to $12 from $14 Hold -"
X Link 2026-01-07T23:01Z [----] followers, [---] engagements

"$CHAG -Jefferies initiates Chagee coverage at Hold $14 target - $CHRW -Baird raises CH Robinson target to $175 from $162 Outperform - $CLX -Goldman lowers Clorox target to $94 from $110 Sell - $CMG -Barclays raises Chipotle Mexican Grill target to $44 from $38 = Weight -"
X Link 2026-01-07T23:37Z [----] followers, [---] engagements

"$DRI -Barclays lowers Darden Restaurants target to $227 from $230 Overweight - $DRUG -Baird raises Bright Minds Biosciences target to $142 from $82 Outperform - $DSGN -Oppenheimer initiates Design Therapeutics coverage at Outperform $18 target - $EAT -Barclays raises Brinker target to $166 from $135 = Weight - https://twitter.com/i/web/status/2009109557231145356 https://twitter.com/i/web/status/2009109557231145356"
X Link 2026-01-08T03:47Z [----] followers, [---] engagements

"$EVMN -Raymond James initiates Evommune coverage with a Strong Buy rating expecting [----] to be a 'catalyst rich year' for the company -Sets $40 target https://www.investing.com/news/analyst-ratings/raymond-james-initiates-evommune-stock-with-strong-buy-rating-40-target-93CH-4435931 https://www.investing.com/news/analyst-ratings/raymond-james-initiates-evommune-stock-with-strong-buy-rating-40-target-93CH-4435931"
X Link 2026-01-08T03:52Z [----] followers, [---] engagements

"$FFAI Faraday Future Announces the FX Super One Roadmap for Mass Production Sales Delivery Service and Ramp-Up and Its Entry into Embodied AI Robotics along with Its Execution Plan for FF's Five-Year Business Plan https://www.stocktitan.net/news/FFAI/faraday-future-announces-the-fx-super-one-roadmap-for-mass-qcxz9o0ovnvm.html https://www.stocktitan.net/news/FFAI/faraday-future-announces-the-fx-super-one-roadmap-for-mass-qcxz9o0ovnvm.html"
X Link 2026-01-08T04:11Z [----] followers, [---] engagements

"$IR -Wells Fargo raises Ingersoll Rand target to $92 from $87 Overweight - $ISRG -Barclays raises Intuitive Surgical target to $686 from $635 Overweight -BTIG lifts target to $616 from $589 Buy -"
X Link 2026-01-08T04:42Z [----] followers, [---] engagements

"$IVA UBS raises Inventiva target to $12 from $3 Upgrades to Buy from Neutral - $JACK -Barclays raises Jack in the Box target to $20 from $15 = Weight - $JBIO -HC Wainwright initiates Jade Biosciences coverage with a Buy rating -Sets $25 target https://www.investing.com/news/analyst-ratings/hc-wainwright-initiates-coverage-on-jade-biosciences-stock-with-buy-rating-93CH-4434865 https://www.investing.com/news/analyst-ratings/hc-wainwright-initiates-coverage-on-jade-biosciences-stock-with-buy-rating-93CH-4434865"
X Link 2026-01-08T04:52Z [----] followers, [---] engagements

"$OGN $DSNKY Organon Enters into a Commercialization Agreement for Daiichi Sankyos Nilemdo in France Denmark Iceland Sweden Finland and Norway https://www.stocktitan.net/news/OGN/organon-enters-into-a-commercialization-agreement-for-daiichi-sankyo-iddich3iv3ia.html https://www.stocktitan.net/news/OGN/organon-enters-into-a-commercialization-agreement-for-daiichi-sankyo-iddich3iv3ia.html"
X Link 2026-01-08T07:00Z [----] followers, [---] engagements

"$INKT MiNK Therapeutics and University of WisconsinMadison Announce Phase [--] Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease https://www.stocktitan.net/news/INKT/mi-nk-therapeutics-and-university-of-wisconsin-madison-announce-hfet62p2xxqm.html https://www.stocktitan.net/news/INKT/mi-nk-therapeutics-and-university-of-wisconsin-madison-announce-hfet62p2xxqm.html"
X Link 2026-01-08T19:25Z [----] followers, [---] engagements

"$DK -Piper Sandler lowers Delek target to $40 from $47 Neutral - $DLTR -Barclays raises Dollar Tree target to $149 from $136 Overweight -Deutsche Bank resumes coverage at Hold $126 target - $DNA -Cowen lowers Gingko Bioworks target to $12 from $14 Buy -"
X Link 2026-01-09T01:40Z [----] followers, [---] engagements

"$DPZ -Evercore lowers Domino's Pizza target to $490 from $510 Outperform - $DRI -Truist lowers Darden Restaurants target to $207 from $240 Downgrades to Hold from Buy - $DUOL -Wells Fargo lowers Duolingo target to $160 from $185 Underweight -"
X Link 2026-01-09T01:47Z [----] followers, [---] engagements

"$IQV -Truist raises IQVIA target to $290 from $265 Buy -UBS lifts target to $280 from $250 Buy - $IRON -Morgan Stanley raises Disc Medicine target to $120 from $115 Overweight - $JACK -Truist raises Jack in the Box target to $18 from $16 Hold -"
X Link 2026-01-09T03:39Z [----] followers, [---] engagements

"$PHR -Wells Fargo initiates Phreesia coverage at Overweight $30 target -Truist lowers target to $24 from $29 Buy - $PSX -Piper Sandler lowers Phillips66 target to $155 from $171 Neutral - $PTCT -Morgan Stanley raises PTC Therapeutics target to $90 from $78 Overweight -"
X Link 2026-01-09T05:15Z [----] followers, [---] engagements

"$STLA -Piper Sandler raises Stellantis target to $15 from $9 Upgrades to Overweight from Neutral - $STZ -UBS reiterates Constellation Brands $170 target Buy -Wells Fargo raises target to $165 from $160 Overweight - $TECX -Truist lowers Tectonic Therapeutics target to $60 from $64 Buy - https://twitter.com/i/web/status/2009498971111117182 https://twitter.com/i/web/status/2009498971111117182"
X Link 2026-01-09T05:34Z [----] followers, [---] engagements

"$TGT -Deutsche Bank resumes Target coverage at Hold $108 target - $TJX -UBS raises TJX Companies target to $193 from $181 Buy -Deutsche Bank sets $184 target Buy - $TNYA -Morgan Stanley lowers Tenaya Therapeutics target to $2 from $5 Overweight -"
X Link 2026-01-09T05:36Z [----] followers, [---] engagements

"$TOST -Wolfe Research downgrades Toast to Peer Perform from Outperform - $TPR -UBS raises Tapestry target to $123 from $105 Neutral - $TRIP -Cantor Fitzgerald lowers TripAdvisor target to $14 from $15 Underweight - $TSCO -Gordon Haskett lowers Tractor Supply target to $50 from $57 Downgrades to Hold from Accumulate - https://twitter.com/i/web/status/2009500268581232979 https://twitter.com/i/web/status/2009500268581232979"
X Link 2026-01-09T05:39Z [----] followers, [---] engagements

"$WAB -Wolfe Research upgrades Wabtec to Outperform from Peer Perform $245 target - $WEN -Truist lowers Wendy's target to $11 from $12 Buy -Evercore lowers target to $9 from $11 In-Line -"
X Link 2026-01-09T05:55Z [----] followers, [---] engagements

"$ZBH -BTIG reiterates Zimmer Biomet $112 target Buy - $ZG -Cantor Fitzgerald lowers Zillow Group target to $68 from $74 Neutral --"
X Link 2026-01-09T06:01Z [----] followers, [---] engagements

"$ADBE -BMO lowers Adobe target to $375 from $400 Downgrades to Market Perform fro Outperform - $ADSK -Rothschild Redburn initiates Autodesk coverage at Buy $375 target - $AEHR -Craig Hallum lowers Aehr Test Systems target to $21 from $24 Hold -"
X Link 2026-01-09T21:33Z [----] followers, [---] engagements

"$CRL -Baird raises Charles River Laboratories target to $224 from $199 Outperform -Mizuho lifts target to $215 from $200 Neutral - $CRWD -Berenberg Bank upgrades CrowdStrike to Buy from Hold - $CTSH -Cowen raises Cognizant target to $84 from $78 Hold -"
X Link 2026-01-10T19:46Z [----] followers, [---] engagements

"$DOCS -Goldman raises Doximity target to $62 from $49 Upgrades to Neutral from Sell - $DXCM -Bernstein lifts DexCom target to $86 from $84 Outperform - $EAT -Citi raises Brinker target to $187 from $176 Buy -Mizuho raises target to $175 from $155 Outperform -"
X Link 2026-01-10T19:51Z [----] followers, [---] engagements

"$LIF -Citi lowers Life360 target to $79.50 from $96.80 Buy - $LINE -Scotiabank lifts Lineage target to $39 from $37 Sector Perform - $LITE -Mizuho raises Lumentum target to $455 from $325 Outperform -"
X Link 2026-01-10T22:19Z [----] followers, [---] engagements

"$PZZA -Mizuho lowers Papa John's target to $40 from $44 Neutral - $QCOM -Mizuho lowers Qualcomm target to $175 from $200 Downgrades to Neutral from Outperform - $QRVO -Mizuho lowers Qorvo target to $85 from $93 Neutral - $QXO -RBC lowers QXO target to $30 from $33 Outperform -"
X Link 2026-01-11T00:29Z [----] followers, [---] engagements

"$RACE -UBS lowers Ferrari target to $555 from $563 Buy -Bernstein maintains $395 target Outperform - $RANI -HC Wainwright reiterates Rani therapeutics $11 target Buy - $RAPT -Piper Sandler initiates Rapt Therapeutics coverage at Overweight $95 target -"
X Link 2026-01-11T00:32Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

creator/x::MarcJacksonLA
/creator/x::MarcJacksonLA